




MODELING OF CHINESE HAMSTER 





zur Erlangung des Grades 
des Doktors der Ingenieurwissenschaften 































MODELING OF CHINESE HAMSTER 





zur Erlangung des Grades 
des Doktors der Ingenieurwissenschaften 



























Tag des Kolloquiums: 08. December 2017 
Dekan: Prof. Dr. G. Kickelbick 
Berichterstatter: Prof. Dr. C. Wittmann 
 
Vorsitz: Prof. Dr. E. Heinzle 
              Prof. Dr. G.-W. Kohring 






“Don’t worry, life is easy.” 
― Aaron  
 
“Have no fear of perfection - you'll never reach it.”  
― Salvador Dali 
 
"I am never content until I have constructed a mechanical model of the subject I am 
studying. If I succeed in making one, I understand; otherwise I do not."  
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Der Schwerpunkt dieser Dissertation liegt auf der systematischen Entwicklung 
Modellen für die Vorhersage des zellulären Stoffwechsels, des Wachstums und der 
Produktion von monoklonalen Antikörpern (mAb) in Kulturen von Chinesischen 
Hamster-Ovarzellen (CHO). Zunächst wurden mit segmentierter linearer Regression 
metabolischer Phasen identifiziert. Diese Identifizierung beruht auf der Annahme 
eines pseudo-stationären Zustands und somit, dass in einer Phase alle Raten linear 
miteinander korreliert waren. Die spezifischen Raten wurden aus den Zeitverläufen 
der Konzentrationen der Metabolite und des mAb sowie der Lebendzellzahl bestimmt. 
Durch die Korrelation konnten alle Raten über die Wachstumsrate im 2 L und im 
2000 L Maßstab berechnet werden. Danach wurde ein kinetisches Modell des 
Wachstums der Zellen etabliert, was die Vorhersage aller Raten auch in fed-batch 
Kulturen erlaubt. Die Kinetik basiert auf der Monod-Kinetik modifiziert mit einer 
variablen maximalen spezifischen Wachstumsrate. Das kinetische Modell erlaubt 
eine rechnerische Optimierung der Substratzuführung für eine maximale 
Produktion. Damit wurde gezeigt, dass aus makroskopischen Daten, d.h. ohne 
intrazelluläre Messungen, wesentliche Informationen erhalten werden können, mit 
denen neue Experimente in einem industriellen Umfeld vorhergesagt werden können. 
Diese innovative und systematische Vorgangsweise eröffnet neue Perspektiven für 
die Reduzierung von Kosten und für eine Beschleunigung der Prozessentwicklung. 





This thesis focuses  on developing a systematic modeling method that can capture the 
essential features for prediction of cell metabolism, growth and monoclonal antibody 
(mAb) production in Chinese Hamster Ovary (CHO) cells. In a first step all specific 
consumption rates are calculated based on time courses of extracellular metabolites, 
viable cell density and mAb. Then the metabolic phases within which the metabolic 
pseudo-steady state approximation is verified are identified. In a third step, all 
metabolic rates are expressed as a function of the specific growth rate within each 
metabolic phase.  
We have applied this method to a set of small bioreactor data and have shown that 
the model obtained can predict specific conversion rates both small and also at large 
scale.   
 
In the second part of this thesis, a kinetic model of the cell growth has been developed. 
Together with previously described methodology, this kinetic model results  in a 
predictive metabolic model for each experimental cell growth data are not required. 
The kinetic model is based on Monod kinetics with a few modifications such as a 
varying the maximum specific growth rate as a function of the integral viable cell 
density. The full kinetic model can be used off line to design optimal feeding profiles. 
The results of this thesis demonstrate that rich knowledge can be derived from 
macroscopic data that can then be used to predict new production conditions in an 





Extended abstract  
The work performed in this thesis demonstrates that a systematic modeling approach 
can be applied to complex bioprocesses. This systematic methodology is based on 
material balances and metabolic networks. It provides  simple and predictive dynamic 
models of Chinese Hamster Ovary (CHO) cell metabolism, cell growth and monoclonal 
antibody (mAb) production based on a limited subset of small scale data. This thesis 
is structured around three major parts that demonstrates how macroscopic modeling 
of the complex metabolism and cell growth of CHO cells leads to predictive models. It 
consists of chapters organized as successive steps building on each other and enabling 
in silico models of bioprocesses. 
 
In the first part (chapter 1), a review of major modeling strategies and methods to 
understand and simulate the macroscopic behavior of mammalian cells is compiled. 
These strategies comprise two important steps: the first step is to identify 
stoichiometric relationships for the cultured cells connecting the extracellular inputs 
and outputs. In a second step, macroscopic kinetic models are introduced. These 
relationships together with bioreactor and metabolite balances provide a complete 
description of a system in the form of a set of differential equations. These can be used 
for the simulation of cell culture performance and further for optimization of 
production. The strategies described in this chapter were used to develop predictive 
models of CHO cells metabolism, cell growth and mAb production in chapter 2 and 
chapter 3. 
 
Chapter 2 focuses on the construction of an apparent simple model of CHO cell 
metabolism during biopharmaceutical production that can be applied across a wide 
range of cell culture conditions, and based on which further developments can be 
designed. This question was addressed through systematic application of the 




cells adapt to the changing extracellular conditions resulting in the development of 
different metabolic phases and related metabolic shifts. This makes modeling of the 
cell metabolism for all phases of cultivation more difficult. In order to deal with this 
complexity, one can identify metabolic phases in which the metabolic pseudo steady 
state approximation is verified, divide the cell culture process into these phases and 
perform separate analyses. This method enables the utilization  of simple 
mathematical procedures to model complex phenomena. Metabolic rates were 
computed based on time series of extracellular metabolites and product 
concentrations as well as viable cell density. For each metabolic phase, cells are 
assumed to be in pseudo-steady state and so the stoichiometric coefficients between 
the specific production rates of metabolites and the specific growth rate are defined 
as constant. The production rates of metabolites were computed and modeled as a 
function of the specific growth rate. First the total number of metabolic steady state 
phases and the location of the metabolic phase breakpoints were determined by 
recursive partitioning. For this, the smoothed derivative of the metabolic rates with 
respect to the growth rate were used followed by hierarchical clustering of the 
obtained partition. Piecewise regression, also called segmented linear regression, was 
then applied to the metabolic rates with the previously determined number of phases. 
This allowed identifying the growth rates at which the cells underwent a metabolic 
shift. The resulting model with piecewise linear relationships between metabolic rates 
and the growth rate did well describe cellular metabolism in the fed-batch cultures. 
Using the model structure and parameter values from a small scale cell culture (2 L) 
training dataset, it was possible to predict metabolic rates of new fed-batch cultures 
just by using the experimental specific growth rates. Such prediction was successful 
both at the laboratory scale with 2 L bioreactors and also at the production scale of 
2000 L. The final mAb titer can also be predicted even if the cells are starved in some 
essential metabolites. This type of modeling demonstrates the feasibility of building 
a reliable and accurate macroscopic model and also provides a flexible framework to 





In the third part of this thesis (chapter 3), a systematic approach is described to 
establish dynamic predictive models of CHO cell growth during biopharmaceutical 
production. Cell growth, cell metabolism and monoclonal antibody (mAb) production 
are predicted by combining an empirical metabolic model with mixed Monod-
inhibition type kinetics that were generalized to every possible external metabolite. 
We describe the maximum specific growth rate as a function of the integral viable cell 
density (IVCD). Moreover, the storage of metabolite in intracellular pools was taken 
into account and was assumed to influence cell growth. This is illustrated with fed-
batch cultures of CHO cells producing a mAb. The impact of two identified and 
selected essential metabolites on cell growth and cell productivity was assessed and 
the macroscopic model was successfully used to predict the impact of new untested 
feeding strategies on cell growth and mAb production. The resulting model combining 
piecewise linear relationships between metabolic rates and the growth rate and 
Monod-inhibition type models for cell growth did well predict cell culture performance 
in fed-batch cultures even outside the range of experimental data used for 
establishing the model. The metabolic model obtained thanks to the methodologies 
presented can predict metabolic fluxes based on small scale data both at small and at 
large scale. It can also predict the cells’ response to different feeding strategies at both 
scales. This is an important step towards reducing the number of bioreactor 
experiments required to control bioreactor production processes and moving towards 
in silico simulations of the impact of process parameters on process yields and cell 
metabolism.   
 
The results of these different steps are discussed in the final conclusion and outlook 
(chapter 5) that summarizes the systematic methodologies developed, describes 






c  Coupled to growth 
nc  Not coupled to growth 
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Aim and outline of the thesis 
The aim of the presented thesis is to provide a systematic methodology for in silico 
prediction of Chinese Hamster Ovary (CHO) cell metabolism and growth which can 
be applied to complex bioprocesses in an industrial setting.. The work is structured 
into three major parts that build upon each other.   
In the first part (chapter 1), we introduce and review major modeling strategies to 
predict the macroscopic behavior of mammalian cells. Here, the advantages of each 
strategy are discussed. This part ensures a smooth introduction to the modeling 
methodologies developed during the thesis and presented in the follow-up studies.  
In the second part of the thesis (chapter 2), a systematic approach to model CHO 
metabolism during biopharmaceutical production across a wide range of cell culture 
conditions was described. Here, the metabolic steady state concept was applied to 
model the production rates of metabolites as a function of the specific growth rate. 
Two powerful methods, piecewise regression and recursive partitioning, were 
combined to identify metabolic shifts and stoichiometric relationships between 
production rates of metabolites and the specific growth rate. This model can be 
applied at various scales to increase its industrial applicability. This model served 
also as starting point to design further in-depth in silico model of CHO cells.   
The third part of the work (chapter 3) presents the second building stone, i.e. the 
development of a systematic approach to model the dynamics of CHO cell growth 
during biopharmaceutical production. This leads to the development of a dynamic in 
silico  macroscopic model of CHO cells. Here, a derivative of Monod type kinetics was 
developed, then the model was calibrated and combined to the metabolic model 
described in chapter 2. The model includes non-constant maximum specific growth 
rate that is dependent on an unidentified inhibitory by-product. Both models 
described in chapter 2 and chapter 3 constitute essential building blocks for the 
development of an in silico macroscopic model of CHO cells. The last section of the 
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1  Macroscopic modeling of mammalian cell 
growth and metabolism 
1.1.     Abstract 
We review major modeling strategies and methods to understand and simulate the 
macroscopic behavior of mammalian cells. These strategies comprise two important 
steps: the first step is to identify stoichiometric relationships for the cultured cells 
connecting the extracellular inputs and outputs. In a second step, macroscopic 
kinetic models are introduced. These relationships together with bioreactor and 
metabolite balances provide a complete description of a system in the form of a set 
of differential equations. These can be used for the simulation of cell culture 













This chapter was published as 
 
Ben Yahia, B., Malphettes, L., Heinzle, E., 2015. Macroscopic modeling of mammalian cell growth 





1.2.     Introduction 
Mammalian cell cultures are the major source of a number of biopharmaceutical 
products, including monoclonal antibodies (Sidoli, Mantalaris et al. 2004, Niklas and 
Heinzle 2012), viral vaccines (Vester, Rapp et al. 2010), and hormones (Nottorf, Hoera 
et al. 2007). Chinese hamster ovary (CHO) cells are widely used as an expression 
system for the synthesis of therapeutic glycosylated proteins (Palomares, Estrada-
Moncada et al. 2004, Zhu 2012). Predicting the behavior of mammalian cells during 
cell culture processes under different culture conditions is highly desirable for both 
commercial and scientific reasons (Kell and Knowles 2006). In batch and fed-batch 
processes, the rate of overproduction of heterogeneous proteins by mammalian cells 
is limited by the decline in cell viability, by the depletion of required metabolites and 
substrates or by the accumulation of metabolic products and inhibitors. Therefore, it 
becomes imperative to identify the parameters which have a significant impact on 
cell viability and on protein production and understand their effects on the cellular 
phenotype. Moreover in 2004, the food and drug administration (FDA) proposed the 
“Quality by Design” (QbD) methodology to biopharmaceutical companies. The focus 
of this concept is that the quality, most important protein glycosylation, should be 
built into a product with a thorough understanding of the product itself and the 
process for its production (Tomba, Facco et al. 2013). Additionally, critical process 
parameters should be identified which have an impact on the critical quality 
attributes (CQAs) of the product (Kontoravdi, Asprey et al. 2007, Teixeira, Oliveira 
et al. 2009, Royle, Jimenez del Val et al. 2013).  
Mammalian cell culture processes are complex (Stelling, Sauer et al. 2006), and 
numerous input parameters have to be identified to optimize growth and productivity 
(Nolan and Lee 2011, Sellick, Croxford et al. 2011, Nolan and Lee 2012). To 
understand biological mechanisms and to optimize production processes, rational 
design guided by experience is the most common method currently used. However, 
experiments are time consuming and expensive to perform, and generally generate 




and the needs of mammalian cells (Sidoli, Mantalaris et al. 2004, Royle, Jimenez del 
Val et al. 2013). They can be used as a prediction tool in simulation and optimization 
(Wiechert 2002, Goudar, Biener et al. 2006). Mathematical models can also help to 
understand and identify mechanisms that cannot be easily identified only with 
experimental data and a pure statistical analysis of them. Therefore, modeling of 
metabolism has become highly desirable in the development process where the 
identification of the parameters impacting the cell culture processes and the 
prediction of the evolution of the processes are important. Identification of yield 
coefficients can be used for this purpose (Chen and Bastin 1996). This creates 
significant added value in terms of cost and time compared to methods that do not 
use models  (Kessel 2011).  
Compared to very detailed cellular models, the benefit of the use of macroscopic 
models is that it is much easier but yet very informative to analyze the cells as a black 
box or grey box rather than to take into account extended details of what happens 
inside the cell (Zamorano, Vande Wouwer et al. 2013). Analysis of intracellular 
metabolites necessary for setting up and tuning detailed kinetic models of 
metabolism is much more complex to perform than extracellular metabolite analysis 
and requires much more sophisticated techniques, particularly for suspended cells 
(Neermann and Wagner 1996, Wahrheit and Heinzle 2013). In addition, the number 
of model parameters in macroscopic models is significantly lower than the number of 
parameters in microscopic models. The identification of parameters is therefore more 
difficult for very detailed microscopic models. 
A mathematical model can be used for different purposes (Ashyraliyev, Fomekong-
Nanfack et al. 2009, Hu and Zhou 2012):  
(1) To summarize a large volume of experimental data; 
(2) To explore concepts and test hypotheses; 
(3) To predict the behavior of the systems under non-tested conditions; 
(4) To identify conditions for optimal performance of a process as defined by 




The extrapolation power of a model cannot be predicted a priori. The probability that 
a model will allow prediction outside the originally observed region is, however, 
increasing if physically meaningful functions are used. In our review we emphasize 
the separation into a material balancing part, the so-called macroscopic reactions, 
and a kinetic part. The material balancing part, i.e. stoichiometry, provides a sound 
basis and must not be violated for keeping predictivity. The kinetic part relies very 
much on the characteristics of the rate determining processes, e.g. saturation kinetics 
of Michaelis-Menten type, allosteric kinetics of Hill-type or structure of feedback 
control loops in biological systems. The appropriate choice of the underlying types of 
mathematical functions is certainly a crucial point in this respect. For certain 
problems, e.g. metabolic network modeling as shown for CHO, the use of ensembles, 
i.e. sets of models with different structures and/or parameter values, seems useful for 
reducing prediction (Villaverde, Bongard et al. 2015). 
In this review, we will present different types of models used in previous work to 
model the metabolism of suspension cells at the macroscopic level, i.e. to model 
extracellular outputs as function of extracellular inputs. This paper is organized as 
follows: (i) the first part introduces the types of models and the existing modeling 
frameworks (Mahadevan and Doyle 2003). (Mahadevan and Doyle) Then, different 
methods for identifying relevant parameters for creating a macroscopic metabolic 
model will be presented. Preliminary work has to be performed to reduce the number 
of parameters to study and to understand which parameters have a significant impact 
on the responses (Mahadevan and Doyle 2003).  (Mahadevan and Doyle) In part 
three, different kinetic models are reviewed. Kinetic models are used after the 
selection of parameters and when the relationships between those parameters are 
defined. (iv) Model calibration and testing are reviewed and (v) applications to process 





1.3.     Types of models 
There are different ways to classify models. The first distinguishes between empirical 
models, also called descriptive models, and mechanistic models. Empirical models use 
a pragmatic description of all the data with any suitable mathematical relationship. 
They only partially take into account the underlying phenomena or physical laws that 
govern the system behavior. Mechanistic models are based on theoretical foundations 
of systems and on known relationships. The predictions of the responses are based on 
biological, chemical and physical input of knowledge.  
Another classification was proposed by Tsuchiya et al. (Tsuchiya, Fredrickson et 
al. 1966) and distinguishes deterministic models and probabilistic models. The first 
is based on continuous variables using differential equations. Reactions and 
interactions are represented as continuous processes (production, consumption, 
growth...) by corresponding mathematical functions. It is appropriate for systems 
composed of a relatively large number of cells, e.g. more than 10,000. This kind of 
model describes the population as average. Probabilistic or stochastic models use 
probability in the formulation of the model and are typically used for a population of 
only few cells or for molecular events with only small number of molecules, e.g. 
transcription. This allows representation of the variability of a population and a 
system. In cell culture the number of cells is usually very large (e.g. >106 cells/mL) 
allowing the preferential use of deterministic models.  
Another classification distinguishes structured, non-structured, segregated and 
non-segregated models. Structured models take into account the cellular reactions 
within cells (Tsuchiya, Fredrickson et al. 1966, Harder and Roels 1982). Structured 
models can describe biological systems in great detail but are more difficult to set up. 
The number of parameters increases with the complexity of the model and with the 
number of intracellular reactions taken into account. In addition, despite the 
enormously increased knowledge about cellular process, there is still a significant 
lack of information about many steps, e.g. transport, control of enzymes activities and 




easier to work with because they analyze the cells as a black or grey box. Intracellular 
reactions are not analyzed in detail. It is assumed, for example, that cell growth 
depends only on extracellular parameters. However, the extended and now easily 
excessible comprehensive knowledge about the biochemical reaction networks and its 
stoichiometry allows the incorporation of this information into macroscopic models. 
Macroscopic models are less accurate than structured models, but easier to set up 
and to apply. Segregated models, as opposite of non-segragated models, describe 
cellular behavior as a function of cell cycles or age of cells (Karra, Sager et al. 2010, 
Meshram, Naderi et al. 2013, García Münzer, Ivarsson et al. 2015, García Münzer, 
Kostoglou et al. 2015, Pisu, Concas et al. 2015). The vast majority of models is non-
structured and non-segregated. 
Neural networks are particularly useful to relate input and output variables to 
each other in complex systems with incomplete or even completely lacking knowledge 
of the systems structure and also in cases with incomplete measurements. 
Mechanistic knowledge can however be introduced by using hybrid models (van Can, 
te Braake et al. 1999, Oliveira 2004). 
 
1.4.     Identification of relevant input-output relationship 
A general macroscopic reaction scheme of macroscopic reactions can be expressed as 
follow  (Bastin and Dochain 1990): 
 
   , , 1,k
k k
i k i j k j
i R j P
k M
   
 
         (1.1) 
where 
• M is the number of reactions 
• 𝜑𝑘 is the kth reaction rate; 
• 𝜉𝑖 and 𝜉𝑗 are the ith and the jth component, respectively; 




• 𝑅𝑘 is the kth set of reactant and catalyst indices; 
• 𝑃𝑘 is the kth set of product and catalyst indices. 
This general reaction scheme represents a macroscopic-stoichiometric relationship. 
To set up such a macroscopic model, the important parameters, i.e. the relevant 
cellular inputs, 𝜉𝑖 , and outputs, 𝜉𝑗 , as well as the stoichiometric coefficients, 
𝜈𝑖,𝑘 , 𝜈𝑗,𝑘 , relating the inputs to the outputs, have to be determined. This can start from 
the increasingly comprehensive knowledge of cellular reactions and transport or, as 
traditionally done, from purely empirical data. Ideally both types of information are 
combined as described below and indicated in Figure 1.1. This step is often the main 
bottleneck in the design of a macroscopic model for complex biotechnological 
processes. 
 
Figure 1.1. Methods to derive macroscopic kinetic models. In order to get a simulation and 
prediction model of the macroscopic cell behavior, first, the macroscopic reactions of the cell culture 
system have to be determined, i.e. the stoichiometry relating input and output of the cells. To do 
that, statistical methods, empirical observations and metabolic network based methods can be used. 
After that, the kinetics of the system have to be described and combined with the stoichiometric 
model. Finally the model is calibrated, usually using optimization based methods, and tested. 
PCA: Principal Component Analysis; MFA: Metabolic Flux Analysis; EFM: Elementary Flux Mode; 





1.4.1. Method based on expert reasoning 
One possible approach to select significant parameters is based on expert reasoning 
and experimental observations. This approach measures correlations between the 
macroscopic outputs we want to model with the cell culture parameters, i.e. the 
macroscopic inputs, under different experimental conditions. A most popular method 
uses the concept of yield coefficients relating always two measured variables to each 
other, e.g. biomass to substrate or product to biomass (Dunn, Heinzle et al. 2003). 
Yield coefficients are frequently used to set up stoichiometric relationships to be 
applied in metabolic flux analysis using metabolite balancing (Niklas, Noor et al. 
2009). It requires little thought about the actual detail of the system and uses most 
significant phenomena observed during experiments to define the extracellular 
parameters such as limiting nutrients or accumulation of side waste products. 
Typically, outputs/inputs taking into account in a macroscopic model with this kind 
of approach are biomass, glucose, glutamine, lactate and ammonia. For instance,  
Jang and Barford (Jang and Barford 2000) developed an unstructured model of 
growth and metabolism of a mouse murine hybridoma AFP-27 cell line producing an 
IgG1 antibody. They assumed that glucose, glutamine, lactate, and ammonia were 
growth limiting. Lactate and ammonia were considered as toxic products of catabolic 
reactions, which inhibit cell growth and can ultimately cause cell death In their 
model, even though they assumed that hybridoma cells can produce monoclonal 
antibodies until any of amino acid is depleted, they only considered glutamine as 
limiting amino acid. Moreover, based on the demonstration of Suzuki and Ollis 
(Suzuki and Ollis 1990), they considered the specific antibody production to be a 
function of the fraction of cells in G1 phases. Acosta et al. (Acosta, Sánchez et al. 2007) 
also assumed this link between specific growth rate and specific productivity in their 
model of IgG2a Mab production in hybridoma cells. Although glucose is generally 
important for cell growth, it was not found to be a limiting nutrient in another model 




certainly a too limited observed experimental space for meaningful extrapolation. 
Lactate and ammonia are assumed to both inhibit and kill cells (Glacken, Adema et 
al. 1988, Batt and Kompala 1989, Ozturk, Riley et al. 1992) but the impact on specific 
antibody productivity was reported as not significant (Ozturk, Riley et al. 1992). Jang 
and Bradford (Jang and Barford 2000) and Dhir et al. (Dhir, Morrow et al. 2000) 
assumed that the lactate production was due to cellular consumption of glucose and 
glutamine. They assumed that the spontaneous degradation of glutamine was 
negligible It is however usually relevant but depends on the used medium and process 
duration (Glacken, Adema et al. 1988, Ozturk and Palsson 1990, Borchers, Freund et 
al. 2013). Amino acid depletion has been considered in another model developed by 
Liu et al. (Liu, Bi et al. 2008). Knowledge about metabolism and its control can be 
incorporated but usually not in a systematic manner. Meshram et al. (Meshram, 
Naderi et al. 2013) developed a macroscopic metabolic model and linked it to a model 
of apoptosis. A dynamic model of mAb synthesis and mAb glycosylation by hybridoma 
was described by Kontoravdi et al. (Kontoravdi, Asprey et al. 2007) using a structured 
model based on the work of Umaña and Bailey (Umaña and Bailey 1997). The 
availability of nutrients such as glucose or glutamine had an impact on protein 
glycosylation. 
Such empirical procedures can be a valuable tool for understanding metabolic 
processes as well as for process design and optimization. They are used to design a 
macroscopic model and select the extracellular parameters which have an impact on 
the response defined. Nevertheless, very little real understanding of the cell culture 
process is obtained with this kind of procedure. 
1.4.2. Method based on statistical tools 
A large number of variables can be identified and quantified due to the recent 
development of high-resolution and high-throughput analytical techniques (Martin, 
Reynolds et al. 2014, Steinhoff, Ivarsson et al. 2014). In this context, it becomes more 




expert judgment. Moreover, the relations of variables are generally dynamic and 
involve temporal dependencies.  
To deal with these challenges, multivariate data analysis methods, e.g. principal 
component analysis (PCA), can be used as a statistical tool to select parameters. PCA 
is a multivariate analysis method based on eigenvalue analysis, which is actually the 
projection of original data onto a new set of axes, i.e., the principal components. PCA 
has been introduced by Pearson (Pearson 1901) and Hotelling (Hotelling 1933) to 
describe the variation of multivariate data in terms of a set of uncorrelated variables. 
It is used to reduce a high-dimensional dataset into fewer dimensions while retaining 
important information. Starting out with high-dimensional noisy experimental data, 
one can reduce the dimensionality and even remove pure random errors by 
determination of significant factors (Malinowski 1991). Using significant factor 
analysis followed by rotation, a stoichiometric model with only two independent, 
physically meaningful reactions were identified for Bacillus subtilis batch culture 
(Saner, Heinzle et al. 1992). Xing et al. (Xing, Li et al. 2008) used a methodology based 
on principal factor analysis (PFA) to identify threshold values of repressing 
metabolites, i.e. ammonium, lactate, osmolality and carbon dioxide levels, on CHO 
growth and protein quality (glycosylation properties) but also to select significant 
inputs. PFA was applied by rotating principal components obtained by PCA and seeks 
physically meaningful linear combinations of variables. In their study, Xing et al. 
determined that ammonia and glucose negatively contributed to cell growth. Lactate 
and osmolality were positively correlated to cell growth and pCO2 levels can reduce 
protein quality above a defined threshold. Multivariate analysis methods can be a 
powerful tool to determine the macroscopic stoichiometry of a biological system that 
cannot easily be determined by intuition. However, it becomes more complex to 
evaluate correlations and to apply this kind of statistical method with time-series 
data with varying number of metabolic phases, particularly in fed-batch cultures. 
Another possibility to deal with this complexity is to use time series data analysis 




hypothesis test used to determine causality among parameters. It was developed by 
Clive Granger (1934-2009), a British economist (Granger 1969). This test has recently 
been used to analyze transcriptomics and metabolomics profiles (Sriyudthsak, 
Shiraishi et al. 2013). Siryudthsak et al. introduced this test to evaluate causality 
among metabolites. Direct relationships between two metabolites were evaluated 
using the bivariate Granger causality test. This method has not yet been used to 
develop macroscopic metabolic reactions and to select the significant input parameter 
but it is expected to be applied in the future.  
Statistical tools are useful when the underlying phenomena are too complex to resolve 
manually, such as multivariate data or temporal data. The two statistical methods 
presented above can help to structure problems, to reduce the dimensionality of the 
problem, to select relevant input and output parameters and to develop a macroscopic 
stoichiometric model. 
1.4.3. Method based on metabolic network knowledge 
The central idea is that the macroscopic behavior of cellular metabolism is the result 
of a combination of intracellular microscopic reactions that are more and more easily 
accessible via public databases. Metabolic networks are represented as a system of 
metabolite balance equations based on stoichiometric reactions. The general goal is 
to identify a minimal set of macroscopic reactions that can then build a sound basis 
for a macroscopic model. 
1.4.4. Network construction 
Metabolic network models of the central metabolism of mammalian cells have been 
built from the available genomic and biochemical information. Multiple databases 
can be used as resource for metabolic network reconstruction. As an example, the 
Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database (Kanehisa, 
Goto et al. 2014)and the BioCyc database collection (Caspi, Altman et al. 2014) are 
important databases that can be used to reconstruct a metabolic network. A number 
of studies have proposed metabolic networks of central metabolisms (Ahn and 




Wahrheit et al. 2014). To set up stoichiometric macroscopic relationships of cell 
metabolism, the main difficulty is the size of the metabolic network which can make 
the decomposition into external macroscopic reactions complex (Rügen, Bockmayr et 
al. 2012). To overcome this problem, metabolic networks can be reduced and 
simplified using computed fluxes in order to detect and remove insignificant 
pathways. 
1.4.5. Metabolic flux analysis 
Metabolic flux analysis (MFA) using metabolite balancing, first applied for 
microorganisms (Aiba and Matsuoka 1978), has been widely applied to mammalian 
cells. Metabolite balancing is a powerful method to quantify the manifestation of a 
phenotype (Varma and Palsson 1994, Goudar, Biener et al. 2006, Goudar, 
Konstantinov et al. 2009, Quek, Dietmair et al. 2010, Niklas, Schräder et al. 2011, 
Sengupta, Rose et al. 2011, Ahn and Antoniewicz 2012, Niklas and Heinzle 2012, 
Antoniewicz 2013, Grafahrend-Belau, Junker et al. 2013, Klein, Heinzle et al. 2013, 
Wahrheit, Niklas et al. 2014). Metabolite balancing is based on the assumption that 
accumulation of intracellular metabolites is insignificant compared to the 
extracellular fluxes in batch and fed-batch cultures (Niklas and Heinzle 2012). This 
assumption is valid for small concentration of intracellular metabolites which is 
usually fulfilled but may deviate to a certain extent for highly concentrated 
metabolites, e.g. of the TCA cycle (Rehberg, Rath et al. 2014). Based on this quasi-
steady state assumption, we can say that the sum of influxes and effluxes of an 
internal metabolite of a metabolic network is equal to zero. 
𝑺 ∙ 𝒗 = 𝟎         (1.2) 
where S is a stoichiometric matrix, based on a defined metabolic network, with each 
row corresponding to a balanced internal metabolite and each column corresponding 
to a flux in the flux vector, v.  
We can then split equation 1.2 to have on one side, the fluxes that are experimentally 
measured (substrates, products, biomass), vm, and on the other side, fluxes that will 





𝑺𝒎 · 𝒗𝒎 = −𝑺𝒄 · 𝒗𝒄        (1.3) 
 
Sm and Sc are the stoichiometric matrices associated to vm and vc respectively. If Sc is 
a square matrix of full rank, the fluxes are calculated by: 
 
𝒗𝒄 = −(𝑺𝒄)
−1 ∙ 𝑺𝒎 ∙ 𝒗𝒎       (1.4) 
 
The uptake and production rates of metabolites are such measurable external fluxes 
that can be related to the specific growth rate, μ, by yield coefficients 𝒀𝑴𝒆𝒕/𝑩𝒊𝒐: 
 
𝒗𝒎,𝒊 = 𝜇 · 𝒀𝑴𝒆𝒕/𝑩𝒊𝒐          (1.5) 
 
Monte-Carlo simulation can be used to get a more precise and realistic estimation of 
the standard deviation of the calculated fluxes. A dynamic metabolic flux analysis 
can also be performed in order to have the profile of the intracellular flux over time 
(Niklas, Schräder et al. 2011, Wahrheit, Nicolae et al. 2014). When metabolite 
balancing is performed, reactions with insignificant fluxes can be identified and then 
deleted from the metabolic network to simplify it.  
1.4.6. Elementary flux mode analysis (EFM) 
EFM analysis can then be applied on a metabolic network as defined in equation 1.2. 
EFM analysis is the calculation of independent, minimal biochemical pathways in a 
metabolic network at steady-state, which are thermodynamically and 
stoichiometrically possible taking into account the irreversibility or the reversibility 
of the reactions (Schuster, Dandekar et al. 1999). There is a distinction between 
external and internal metabolites. A ‘flux mode’ is a steady-state flux distribution in 
which the proportions of fluxes are fixed and it is called ‘elementary’ if it is not 




Sahle et al. 2006), Metatool (Schuster and Schuster 1993), efmtool (Terzer and 
Stelling 2008) or CellNetAnalyser (Klamt and von Kamp 2011). 
To perform EFM, the stoichiometric matrix based on a metabolic network is used, 
and the convex basis vectors are computed using equation 1.2, taking into account 
the thermodynamic feasibility constraints (Schuster, Dandekar et al. 1999). Any 
possible flux distribution v can be expressed as a non-negative linear combination of 
a set of elementary flux vectors ei which represent the not decomposable metabolic 
paths between the substrates and the final products: 
 
𝒗 = 𝝎𝟏𝒆𝟏 + 𝝎𝟐𝒆𝟐 + ⋯ + 𝝎𝒑𝒆𝒑                𝝎𝒊 ≥ 𝟎    (1.6) 
 
 The non-negative matrix E with column vectors ei satisfies S·E=0. E constitutes the 
admissible flux space also known as the convex polyhedral cone (Gagneur and Klamt 
2004). However, a critical issue in EFM is the calculation of these elementary flux 
vectors because of dramatically increasing computational demands with increasing 
network size. Based on the matrix E, a set of macroscopic reactions of the 
extracellular metabolites can be derived (Provost and Bastin 2004, Provost, Bastin et 
al. 2006, Gao, Gorenflo et al. 2007, Dorka, Fischer et al. 2009, Baughman, Huang et 
al. 2010, Niu, Amribt et al. 2013, Zamorano, Vande Wouwer et al. 2013). Examples 
of the stoichiometric matrix E are presented in Table 1.1. A methodology was 
proposed by Junger et al. (Jungers, Zamorano et al. 2011) to compute minimal 
elementary decompositions of metabolic flux vectors. Later Zamorano et al. 
(Zamorano, Vande Wouwer et al. 2013) showed that this method allows the 
estimation of metabolic fluxes even with an underdetermined mass balance system 
where data are not sufficient to uniquely define these fluxes. This provides also an 
excellent basis for setting up macroscopic models. 
The output of these approaches are stoichiometric macroscopic relationships of cell 
metabolism based on a metabolic network and on biological and biochemical 





1.5.     Macroscopic kinetic models 
After a first screening to select input parameters and to set up the stoichiometric 
macroscopic reactions, the macroscopic kinetic reactions can be developed. Different 
types of kinetics are available and this section will present some of the most 
important ones.  
1.5.1. Monod model and its derivatives 
For modeling of mammalian cell culture kinetics, the Monod equation and derivations 
of it are most frequently applied. These kinetics with slight modifications are capable 
to simulate different types of characteristics like saturation, inhibition and limitation 
by substrates and other components. 
For Monod kinetics the growth is defined as: 
 
𝝁 = 𝝁𝒎𝒂𝒙 [∏
𝑺𝒊
𝑺𝒊+𝑲𝑺𝒊
]        (1.7) 
 
Where µ is the specific growth rate; Si and KSi are the corresponding substrate 
concentration and half-saturation constant, respectively. µmax is the maximum 
specific growth rate. To incorporate inhibitory effects a corresponding term is added 
to the denominator. In the case of balanced growth all other rates can be related to µ 





Table 1.1 Stoichiometric matrices of macroscopic reaction networks for CHO cell lines 
(Dorka, Fischer et al. 2009) 
            
 e1 e2a e2b e3 e4 e5 e6 e7 e8 e9 e10 
Glucose -1 -1 -1 -1 0 0 0 -0.0508 0 0 0 
Gln 0 -2 0 0 0 0 -1 -0.0577 -0.0104 -1 0 
Lac 2 0 2 2 0 0 0 0 0 0 0 
Glu 0 2 -2 -2 -1 0 1 -0.0016 -0.0107 1 -1 
Asn 0 0 0 0 0 -1 1 -0.006 -0.0072 0 0 
Asp 0 0 0 0 0 1 -1 -0.0201 -0.0082 0 0 
Ala 0 2 2 0 0 0 0 -0.0133 -0.011 0 0 
Pro 0 0 0 0 1 0 0 -0.008 -0.0148 0 0 
BM 0 0 0 0 0 0 0 1 0 0 0 
Mab 0 0 0 0 0 0 0 0 1 0 0 
            
 
 e1 e2 e3 e4 e5 e6 e7 
Glc -1 -1 0 0 0 -1 -1 
Gln 0 0 -1 -1 -1 -3 -2 
Lac 2 0 0 1 0 0 0 
NH3 0 0 1 2 2 1 1 
Ala 0 0 1 0 0 0 0 
CO2 0 6 2 2 5 2 2 
Nucl 0 0 0 0 0 1 1 
        
(Provost and Bastin 2004) 
(Gao, Gorenflo et al. 2007) 
          
 e1 e2 e3 e4 e5 e6 e7 e8 e9 
Glucose -1 -1 -1 0 0 0 -0.0508 0 0 
Gln 0 0 0 0 0 -1 -0.0577 -0.0104 -1 
Lac 2 2 2 0 0 0 0 0 0 
NH3 0 0 0 0 1 0 0 0 1 
Glu 0 -2 -2 -1 0 1 -0.0016 -0.0107 1 
Asn 0 0 0 0 -1 1 -0.006 -0.0072 0 
Asp 0 0 2 0 1 -1 -0.0201 -0.0082 0 
Ala 0 2 0 0 0 0 -0.0133 -0.011 0 
Pro 0 0 0 1 0 0 -0.0081 -0.0148 0 
CO2 0 2 6 0 0 0 0 0 0 
BM 0 0 0 0 0 0 1 0 0 
Mab 0 0 0 0 0 0 0 1 0 
          
(Baughman, Huang et al. 2010) 
          
 e1 e2 e3 e4 e5 e6 e7 e8 e9 
Glc 











Lac 2 2 2 0 0 0 0 0 0 
NH3 0 0 0 0 1 0 0 0 1 
Glu 

























Pro 0 2 0 0 0 0 0 0 0 
BM 0 0 0 0 0 0 1 0 0 
Mab 0 0 0 0 0 0 0 1 0 
          
 
Glc: Glucose; Lac: Lactate; BM: Biomass; Mab: Monoclonal antibody; Nucl: Nucleotides; amino acids are specified 




There are two methods for estimation of the specific growth rate, µ, and the associated 
Monod constant, KSi. One is the steady-state measurement of growth and the limiting 
substrate concentration in continuous culture at different dilution rates. An 
alternative method is the measurement of growth rate at different substrate 
concentrations in batch culture (Banerjee 1993). To estimate the specific growth rate, 
µ, the associated Monod constant, KSi, were arbitrarily set to small values to obtain 
balanced growth (Provost, Bastin et al. 2006, Dorka, Fischer et al. 2009). This seems 
well justified for batch cultures but will not allow to transfer such a model to 
continuous or fed-batch processes without readjustment of these constants. Monod-
type models are widely used, but it is often difficult to define which formulation is the 
best to characterize the cell behavior (Bastin and Dochain 1990). Furthermore, the 
finding the optimal formulation of this kind of model and estimating model 
parameters can be time-consuming. Table 1.2 presents kinetic growth models used in 
the literature to describe growth of different organisms. Generally, only the growth 
rate is described by a Monod-type model, the other components, products and 
substrates, are then described by simple mass balance equations (Sainz, Pizarro et 
al. 2003, Baughman, Huang et al. 2010, Xing, Bishop et al. 2010, Borchers, Freund 
et al. 2013) also called first principle models (FPMs) . To describe the relationship 
between the variation of substrates and products with the cell number, the mass 
balance equations are defined as a set of ordinary differential equations (ODEs) based 
on biological knowledge and taking into account the inner structure of the cells. Often 
the specific consumption/production rates are assumed to be proportional to the 
specific growth rate during the process but this is not always the case. Monod type 
models can also be used to describe other specific consumption/production rates of 
metabolites independent of growth (Provost and Bastin 2004, Gao, Gorenflo et al. 
2007, Dorka, Fischer et al. 2009, Baughman, Huang et al. 2010). Batt and Kompala 
(Glacken, Adema et al. 1988, Batt and Kompala 1989, Ozturk, Riley et al. 1992) 
described a four-compartment structured model to describe growth of hybridoma and 




Table 1.2 Kinetic models for mammalian cell growth 
Kinetic 
parameters  
Cells References Growth equations 
𝜇𝑚𝑎𝑥= 0.125 h-1 
𝑘𝑔𝑙𝑛= 0.8 mM 
𝑘𝑙𝑎𝑐= 8 mM 
𝑘𝑎𝑚𝑚= 1.05 mM 
Hybridoma 
(Bree, Dhurjati et al. 
1988) 










𝜇𝑚𝑎𝑥= 0.055 h-1 
(𝑘𝑠)0= 26.5 
𝛽= 0.21 
𝑘𝑔𝑙𝑛= 0.15 mM 
𝑘𝑎𝑚𝑚= 26 mM2 
Hybridoma 
(Glacken, Adema et al. 
1988) 
𝜇 = 𝜇𝑚𝑎𝑥 ∗
𝑺𝒆𝒓 ∗ 𝑮𝒍𝒏
(𝑺𝒆𝒓 + (𝑘𝑠)0 ∗ 𝑋









(Ozturk and Palsson 
1991) 




𝜇𝑚𝑎𝑥= 0.045 h-1 
𝑘𝑔𝑙𝑐= 1 mM 
𝑘𝑔𝑙𝑛= 0.3 mM 
Hybridoma 
(de Tremblay, Perrier et 
al. 1992) 







𝜇𝑚𝑎𝑥= 0.036 h-1 
𝑘𝑔𝑙𝑛= 0.06 mM 
Hybridoma 
(Pörtner, Schilling et al. 
1996) 




𝜇𝑚𝑎𝑥= 0.689 h-1 
𝑘𝑔𝑙𝑐= 4.79 mM 
𝑘𝑔𝑙𝑛= 0.032 mM 
𝑘𝑙𝑎𝑐= 0.67 mM 
𝑘𝑟𝑑= 0.019 h-1 
𝑘𝐴= 0.275 h-1 












− 𝑘𝐴 ∗ 𝑨𝒎𝒎 
𝜇𝑚𝑎𝑥= 0.065 h-1 
𝑘𝑔𝑙𝑐= 0.75 mM 
𝑘𝑔𝑙𝑛= 0.075 mM 
𝑘𝑙𝑎𝑐= 90 mM 
𝑘𝑎𝑚𝑚= 15 mM 
Hybridoma (Jang and Barford 2000) 













𝜇𝑚𝑎𝑥= 0.028 h-1 
𝑘𝑔𝑙𝑐= 0.084 mM 
𝑘𝑔𝑙𝑛= 0.047 mM 
𝑘𝑙𝑎𝑐= 43 mM 
𝑘𝑎𝑚𝑚= 6.51 mM 
CHO (Xing, Bishop et al. 2010) 
𝜇𝑚𝑎𝑥= 0.0190 h-1 
𝑘𝑔𝑙𝑐= 1.45 mM 
AGE1.HN  
(Borchers, Freund et al. 
2013)  




Glc: Glucose; Gln: Glutamine; Lac: Lactate; Amm : Ammonium. 
*kinetic model of growth in 500mL stirred tank reactors  
 
1.5.2. Logistic equation 
Verhulst (Vogels, Zoeckler et al. 1975) developed the first logistic equation to describe 




term, K, called the overall saturation constant to the first model of Malthus to 
represent the resistance to growth up to a certain limit value of biomass concentration 




= 𝒓 · 𝑿(𝒕) · (𝟏 −
𝑿(𝒕)
𝑲
)        (1.8) 
 
This model does not take into account the death of cells, either by necrosis or 
apoptosis, observed in mammalian cell processes. Therefore cell growth and death 
have been taken into account in an alternative formulation, the so-called four-
parameter-generalized-logistic-equation which can describe cell density profiles in 
batch and fed-batch cultures (Jolicoeur and Pontier 1989). 
 
𝑿(𝒕) =  
𝑨
𝒆𝑩𝒕+𝑪𝒆−𝑫𝒕
        (1.9) 
 
Where X(t) is the cell density at time t. A is related to the initial value of X while B 
and C correspond to the maximum death and growth rate, respectively. Goudar 
(Goudar 2012) applied such logistic modeling in batch and fed-batch cultures of 
mammalian cells. To describe the cell culture process system, besides equation 1.9 
two types of equations were used for the formation of products and for substrate 
consumption.  
The second type of equation used was the logistic growth equation to describe 
monotonously increasing quantities of product concentrations, P, such as lactate and 
ammonium 
 
𝑷(𝒕) =  
𝑨
𝟏+𝑪𝒆−𝑫𝒕





Finally the logistic decline equation has been used to describe monotonously 
decreasing quantities of nutrient concentration, N, such as glucose or glutamine 
concentration. 
 
𝑵(𝒕) =  
𝑨
𝐞𝑩𝒕+𝑪
          (1.11) 
 
To get robust logistic modeling, initial estimation of parameters using linearization 
have been successfully used. More complex equations can be used. For instance, 
Acosta et al. (Acosta, Sánchez et al. 2007) use two asymmetric logistic equations for 
growth and nutrients and products. Logistic equations have been successfully used 
in a variety of applications to describe the dynamic of population growth, most of 
them involved bacterial growth (Gibson, Bratchell et al. 1987, Tsoularis and Wallace 
2002) but also mammalian cell growth (Goudar, Joeris et al. 2005, Goudar, 
Konstantinov et al. 2009, Goudar 2012, Goudar 2012). This kind of models are 
particularly useful if the matrix S from equation 1.2 is not known. 
The main differences between the logistic equation and the Monod model are that the 
logistic equation uses fewer parameters compared to the Monod model and that it 
does not require knowledge about limiting substrates. That makes the computational 
step from logistic approach simpler than classical approaches but seems less suited 
for extrapolation and not suited to incorporate additional information on metabolism.  
1.5.3. Neural networks and hybrid models 
Neural Networks (NNs) are computational models of black-box type. They are used 
to model a wide spectrum of problems. NNs are an interconnected network structure 
composed of a set of processing elements (PEs) (Price and Shmulevich 2007). Giving 
some input, computations are made using the transfer functions of the network to 
estimate the output. The network is composed of different layers: the input layer, the 




(polynomial, hyperbolic, kernel, …) and the significance of the connection is called 
the weight. 
Marique et al. (Marique, Cherlet et al. 2001) used a NN to simulate nonlinear kinetics 
of CHO strains. For the transfer function, a classical sigmoid function was applied. 
Biomass, glucose, glutamine, lactate and ammonia concentrations represented 
output and input layers. A model with CHO K1 of those five variables was obtained 
by using only one hidden layer. Moreover, the same NN has been used to predict the 
behavior of another cell line (CHO TF70R) by adjusting the time scale. As described 
above, mechanistic knowledge is not needed to create NNs. Nevertheless, hybrid 
neural networks are more used since a decade, combining non-parametric functions 
such as NNs and parametric functions based on cell culture process knowledge (van 
Can, te Braake et al. 1999, Vande Wouwer, Renotte et al. 2004, Laursen, Webb et al. 
2007). Laursen et al. combined material balances to estimate accumulation rates of 
biomass, product and metabolites in a bacterial fed-batch culture combined with a 
NN for each variable. Vande Wouver et al. (Vande Wouwer, Renotte et al. 2004) used 
several hybrid NNs to describe CHO batch cultures. A set of NNs for the calculation 
of the  reaction  rates  was combined with material balances of a bioreactor (Chen, 
Bernard et al. 2000). Teixeira et al. (Teixeira, Alves et al. 2007) used EFM to reduce 
the metabolic network of a recombinant Baby Hamster Kidney (BHK-21A) cell line 
producing a glycoprotein (IgG1-IL2) to a minimal set of macroscopic reactions which 
then served as a basis for a hybrid NN model. A three-layered backpropagation neural 
network was used as a non-parametric function to describe the kinetics of the system. 
By using this hybrid model in a fed-batch process, they were able to increase the final 
productivity of IgG1-IL2 by 10% (Teixeira, Alves et al. 2007). Graefe et al. (Graefe, 
Bogaerts et al. 1999) applied a serial hybrid model to CHO-K1 by combining mass 
balances and neural network kinetics. A convincing prediction of components 
concentrations in the stirred tank bioreactor was achieved.  
Hybrid models exploit the advantages of parametric models (“grey box model”) and of 




individually. For complex problems, this kind of methodology provides a good 
benefit/cost ratio. 
To conclude, logistic models and neural network models do not or only partially 
consider the underlying physical, biological phenomena. Nevertheless, they are less 
difficult to develop than mechanistic models. There parameters are hardly physically 
interpretable in contrast to mechanistic models that take into account the underlying 
phenomena including mass balances which supports biological understanding. 
Moreover, mechanistic type models are generally more suited for extrapolation 
outside the experimentally explored space. For very complex systems with limited 
mechanistic knowledge available, logistic models and NNs can be useful due to the 
lower number of parameters to identify. Hybrid models take the advantages of both 
approaches, the mechanistic approach and the empirical/semi-empirical approach, 
e.g. by improving model extrapolation compared to a pure NN (Van Can, Te Braake 
et al. 1998) but require complex optimization tools to calibrate them.  
 
1.6.     Model calibration and testing   
Before starting to identify model parameters, it is important to identify and remove 
outliers. Outliers can increase the level of variance of the model parameters (Yang, 
Martin et al. 2011), can reduce the model performance by biasing parameter 
estimates and can lead to false conclusion. Outliers are often due to fault, biological 
deviations or human/instrumental errors. For instance Borchers et al. (Borchers, 
Freund et al. 2013) defined an outlier detection approach for AGE1.HN cell line based 
on a model (model generic approach) by introducing an additional pessimistic bound 
(relative error). Then, they identified model parameters and performed a reachability 
analysis. The outliers were then selected by comparing the reachable state sets with 
the measurements data. There are many other possible methods to identify outliers 
like the locally estimated scatterplot smoother (LOESS) (Sriyudthsak, Shiraishi et 
al. 2013) or using splines (Laursen, Webb et al. 2007) but most of them depend on the 




Kinetic parameters are usually determined by fitting the model to the experimental 
data. Parameter estimation is an optimization problem, in which an objective or cost 
function characterizing the deviation of a model prediction from the experimental 
data is minimized by adjusting model parameters. Typically least squares or the 
maximum likelihood functions are applied. Together with the usually non-linear 
differential equations of the model, non-convex problems result that are hard to solve 
but powerful algorithms and mathematical tools have been developed to treat them. 
These were successfully applied to macroscopic models of mammalian cells. For 
instance Borchers et al. (Borchers, Freund et al. 2013) used a semi-definite 
programming (SDP) algorithm to solve a polynomial function by reformulating and 
relaxing the non-convex constraint problem into a convex optimization problem, 
whereas Baughman et al. (Baughman, Huang et al. 2010) used a simple discretization 
scheme combined with a filtered interior point primal dual line search algorithm 
(IPOPT) to identify global optima for the non-convex problem.  
The choice of optimization algorithms depends on the type of optimization problem, 
the number of parameters and variables, the constraints, the model but also software 
availability, e.g. gOPT from gPROMs (Kontoravdi, Asprey et al. 2007), ADMIT 
toolbox (Streif, Savchenko et al. 2012, Borchers, Freund et al. 2013) and MATLAB 
(MathWorks, Natick, MA) (Sainz, Pizarro et al. 2003, Vande Wouwer, Renotte et al. 
2004, Teixeira, Alves et al. 2007). 
Goudar et al. (Goudar, Konstantinov et al. 2009) compared the simplex method, the 
generalized reduced gradient method (GRG) and the Levenberg-Marquard algorithm 
(LMA) for nonlinear parameter estimation of logistic model parameters of batch and 
fed-batch mammalian cell culture. The simplex method and GRG methods resulted 
in a better fit than LMA. LMA was also used by Vande Wouwer et al. (Vande Wouwer, 
Renotte et al. 2004) for batch CHO cell culture. LMA was applied in the training 
process for hybrid models of bioprocesses (Graefe, Bogaerts et al. 1999). Dorka et al. 
(Dorka, Fischer et al. 2009) successfully identified Monod-type parameters of 




(QP). For the post-exponential phase, the maximal rates and the half saturation 
constants were calibrated using a Markov chain Monte Carlo method (MCMC) using 
a Metropolis-Hasting algorithm. More examples of applications of optimization 
algorithms for macroscopic modeling of mammalian cells can be found in a number of 
studies, e.g. the method of Powell (Glacken, Adema et al. 1988), MCMC (Xing, Bishop 
et al. 2010), linear programming (Sainz, Pizarro et al. 2003), the particle swarm 
algorithm (PSO) (Selişteanu, Șendrescu et al. 2015), sequential quadratic 
programming (SQP) (Kontoravdi, Asprey et al. 2007) and a quasi-Newton method 
(Teixeira, Alves et al. 2007). It is not possible to a priori recommend any single 
algorithm as the superior method as it is problem-dependent. 
Major problems of parameter estimation in non-linear systems are the potential 
existence of multiple local minima and over fitting. Additionally, models have to be 
assessed for their predictive power and their robustness against perturbations. 
Model validation is one of the most critical parts of the modeling process. We can 
identify two ways to evaluate the quality of a model: one called direct validation 
compares the model prediction with the same experimental data as used to estimate 
the parameters (Goudar, Konstantinov et al. 2009, Selişteanu, Șendrescu et al. 2015). 
The second method uses an independent new data set to validate or invalidate the 
model (cross validation). For instance Xing et al. (Xing, Bishop et al. 2010) identified 
the parameters on three independent sampling trains with different initial 
parameters and then used two types of validation. The first one validated the model 
by applying the model to different cell cultures to assess the applicability of the model. 
Secondly, they applied the model to a perturbed system to assess the accuracy of the 
model. For hybrid neural models, two data sets, one training/calibration data set to 
identify hybrid model parameters and one validation data set to assess the model 
quality are usually used (Oliveira 2004, Vande Wouwer, Renotte et al. 2004, Teixeira, 
Alves et al. 2007).  
A more complex methodology was used by Borchers et al. (Borchers, Freund et al. 




method builds on a semi-definite programming relaxation and outer-bounding 
techniques supported by the ADMIT toolbox (Streif, Savchenko et al. 2012).  
Another important method to assess the quality of a model is to perform sensitivity 
analysis that can provide valuable information regarding the importance of 
parameters on the model output and on the possible impact of variability of the input 
on the output. For instance, one can evaluated the largest possible variation of the 
parameters which does not lead to rejection of the model (Borchers, Freund et al. 
2013). Baughman et al. (Baughman, Huang et al. 2010) quantified the impact of the 
linear discretization on the parameters and on the numerical error. Moreover, the 
impact of possible measurement variability on model estimate has been performed by 
using Monte Carlo simulation using normal distribution (Baughman, Huang et al. 
2010).  Global sensitivity analysis (GSA) has the advantage of evaluating the effect 
of a factor while all other factors are varied simultaneously (Kiparissides, Rodriguez-
Fernandez et al. 2008). For instance Kontoravdi et al. (Kontoravdi, Asprey et al. 2007) 
used the Sobol’ global sensitivity method to assess the sensitivity of the parameters 
of dynamic hybridoma model and, based on the same case study, Kiparissides et al. 
(Kiparissides, Rodriguez-Fernandez et al. 2008) evaluated the performance of the 
Sobol’ method and derivative based global sensitivity measures (DGSM) as a GSA 
method. The DSGM method was identified as more useful than the Sobol’ method due 
to the lower computational requirement while producing the same quality of results. 
 
1.7.     Application of models for control of processes 
An important application for industrial production is the use of macroscopic models 
for the control of production processes. Generally, models applied for control should 
be simple and variations of process conditions and cell characteristics can be taken 
into account by adapting the model parameters online. It is most straightforward to 
use a stoichiometric model together with dynamic material balances to estimate the 
state of a culture. A feeding strategy can be determined in a fed-batch process based 




Lane et al. 2001) used an open-loop-feedback-optimal controller to maintain glucose 
and glutamine at low levels in a culture of a hybridoma cell line producing an IgG 
antibody. This controller was based on a Monod-type model of growth in which the 
parameters and the state are estimated, and then an optimization part calculates an 
optimal feeding profile. Teixeira et al. (Teixeira, Alves et al. 2007) also used a 
controller with an hybrid model on a culture of a BKH cell line producing an IgG1-
IL2. The glucose and glutamine feeding rate was optimized to maximize the total 
amount of antibody produced at the end of the experiment. Finally, Craven et al. 
(Craven, Whelan et al. 2014) used a non-linear model predictive controller (NMPC) 
in a CHO cell line to control the glucose concentration. The kinetic models used were 
of Monod type. 
 
1.8.     Conclusion and outlook 
As was described in this review, setting up of macroscopic models is carried out in 
primarily two steps (Figure 1.1) After identification of the stoichiometric part of a 
model, kinetics for growth and metabolite conversion are defined to yield relatively 
simple yet useful combined models. As in most other cases of modeling, macroscopic 
modeling of mammalian cell cultures is an iterative process of setting up a model, 
calibrating, validating and testing it, designing and performing new experiments and 
revising the model.  
Macroscopic modeling of metabolism can be used in many applications to accelerate 
cell line selection, medium optimization, feeding strategy development, and other 
bioprocess development activities. By using macroscopic models, it is possible to 
understand what the significant parameters are that have an impact on the cell 
culture process and then predict how the process will evolve if one parameter is 
changed. Having predictive models of cell culture processes can be a powerful tool to 
help identifying the critical process parameters which have an impact on CQAs, e.g. 
glycosylation, and to optimize process performance with respect to a defined objective 




biopharmaceutical companies. They also assist in fulfilling requirements of the QbD 
methodology by providing a handle to further improve CQAs.  
For fed-batch cell culture processes, macroscopic models can be applied to predict the 
time courses of metabolites which have significant impact on the cell culture process 
or to estimate process rates of interest and then control feeding rates based on model 
prediction and using an appropriate objective function.  
Different types of models can be used to select variables and determine the 
macroscopic reactions of the system and then, different kinetic models can be applied 
to simulate and predict the macroscopic behavior of the cells. All types of 
combinations of those model can be applied; for example, a stoichiometric model using 
the EFM method combined with a logistic kinetic equation or empirical stoichiometric 
relationships identified with a PCA combined with a Monod-type kinetic equations 
and so on. Stoichiometry derived by the EFM method are used together with NNs to 
result in so-called hybrid neural network models. Such kind of hybrid models are 
more of grey-box rather than black-box type (van Can, te Braake et al. 1999, Vande 
Wouwer, Renotte et al. 2004, Laursen, Webb et al. 2007). The choice of the model 
depends on the aim of the study but also on the complexity of the system we want to 
simulate and understand. As summary of strategies used to develop macroscopic 
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2 Segmented linear modeling of CHO fed-batch 
culture and its application to large scale 
production 
2.1.     Abstract 
We describe a systematic approach to model CHO metabolism during 
biopharmaceutical production across a wide range of cell culture conditions. To this 
end, we applied the metabolic steady state concept. We analyzed and modeled the 
production rates of metabolites as a function of the specific growth rate. First the 
total number of metabolic steady state phases and the location of the breakpoints 
were determined by recursive partitioning. For this the smoothed derivative of the 
metabolic rates with respect to the growth rate were used followed by hierarchical 
clustering of the obtained partition. We then applied a piecewise regression to the 
metabolic rates with the previously determined number of phases. This allowed 
identifying the growth rates at which the cells underwent a metabolic shift. The 
resulting model with piecewise linear relationships between metabolic rates and the 
growth rate did well describe cellular metabolism in the fed-batch cultures. Using the 
model structure and parameter values from a small scale cell culture (2 L) training 
dataset, it was possible to predict metabolic rates of new fed-batch cultures just using 
the experimental specific growth rates. Such prediction was successful both at the 
laboratory scale with 2 L bioreactors but also at the production scale of 2000 L. This 
type of modeling provides a flexible framework to set a solid foundation for metabolic 
flux analysis and mechanistic type of modeling.  
This chapter was published as 
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2.2.     Introduction 
 Fed-batch cultivation of Chinese hamster ovary (CHO) cells is a widely used 
technology for the production of therapeutic glycosylated proteins (Sidoli, Mantalaris 
et al. 2004, Niklas and Heinzle 2012, Tsang, Wang et al. 2014, Tescione, 
Lambropoulos et al. 2015). So far, process development of mammalian cells producing 
monoclonal antibodies (mAb) and other biopharmaceuticals has been largely done by 
designing and performing experiments in an empirical manner. In the attempt to 
understand the mechanism determining such production in-depth, systems biology 
methods, i.e. genomic, transcriptomic, proteomic and metabolomic analyses are 
increasingly applied together with associated modeling. For process development 
mainly two methods were already used to get a better understanding of cellular 
metabolism as a basis for process optimization. On the one side, mechanistic 
metabolic modeling (Ashyraliyev, Fomekong-Nanfack et al. 2009, Hu and Zhou 2012) 
is used to describe the physiological behavior of cells and further to optimize 
cultivation and production (Dorka, Fischer et al. 2009, Nolan and Lee 2011). On the 
other side, metabolic flux analysis (Niklas and Heinzle 2012) quantifies the 
intracellular fluxes and therefore provides a better understanding of cellular 
physiology (Provost and Bastin 2004, Provost, Bastin et al. 2006, Dorka, Fischer et 
al. 2009, Jungers, Zamorano et al. 2011, Naderi, Meshram et al. 2011, Nolan and Lee 
2011, Amribt, Niu et al. 2013, Meshram, Naderi et al. 2013, Zamorano, Vande 
Wouwer et al. 2013). During cultivation, cells adapt to the extracellular environment 
that changes due to the successive consumption and depletion of substrates and the 
accumulation of waste byproducts. Different metabolic phases linked by metabolic 
shifts are the results of this (Wahrheit, Nicolae et al. 2014, Wahrheit, Niklas et al. 
2014, Mulukutla, Yongky et al. 2015). This makes mechanistic modeling of the 
metabolism for the duration of a whole bioproduction difficult. Metabolic flux analysis 
requiring a metabolic steady state is then only applicable for each metabolic phase 
individually. However, metabolic phases with metabolic steady state have to be 




Heinzle 2012). Usually, cell cultivation is divided into phases based on the growth 
profile (Altamirano, Illanes et al. 2001, Altamirano, Illanes et al. 2006, Niklas, 
Schräder et al. 2011, Wahrheit, Nicolae et al. 2014). This procedure is performed 
manually from visual inspection of cell growth (Dean and Reddy 2013, Fan, Jimenez 
Del Val et al. 2015) but can also be based on non-linear models such as Neural 
Network (Simon, Karim et al. 1998) or on a structural approach (Borchers, Freund et 
al. 2013). However, these methods focus on growth phases and may thus miss 
metabolic shifts that are only seen by observing the yield coefficients between 
metabolite consumption/production and cell growth. Identification of growth phases 
based on growth profiles is even more difficult in fed-batch cultures with their varying 
conditions. To overcome this problem, the concept of metabolic-steady state has been 
applied and extended. Under such conditions, intracellular fluxes or, at least, flux 
ratios remain constant. Moreover, biomass yields on substrates as well as on all 
precursor molecules are constant; that can be proven by the identification of linear 
correlations between metabolic rates (Deshpande, Yang et al. 2009).  
The aim of the prevailing work is to provide a systematic methodology for identifying 
metabolic phases and for simulating the evolution of cell metabolism based on the 
relationship between external metabolite rates and the specific growth rate. For that 
purpose, segmented linear regression, also called piecewise regression, was used 
(McGee and Carleton 1970, Muggeo 2003, Toms and Lesperance 2003). In segmented 
regression models two or more regression lines are joining at unknown points, called 
breakpoints. Using the growth rate as a criterion to identify metabolic phases and 
predict cell metabolism provides the unique possibility to compare various states of 
growth. Finally, this new methodology can be used without any assumed metabolic 
network model. This method is illustrated with the example of a Chinese hamster 
ovary (CHO) cells cultivated in fed-batch production at 2 L scale that was used to 
establish and calibrate the piecewise model. The model was then validated for its 




2.3.     Modeling and theoretical aspects 
2.3.1. General Representation and Metabolic Steady-State 
Assumption 
Metabolic phases are defined by a metabolic steady state such that intracellular 
metabolite concentrations remain constant within a phase (Provost, Bastin et al. 
2006). If all intracellular concentrations remain constant, then metabolic fluxes as 
well as yield coefficients are constant (Deshpande, Yang et al. 2009). Moreover, the 
consumption of substrates can be separated into a part associated with growth and 
into one not consumed in association with growth, e.g. for maintenance purposes or 
for the synthesis of products in a non-growth associated manner (Pirt 1965, Pirt 
1982). A metabolic-steady state can in principle be reached in any cultivation 
including batch and fed-batch processes where extracellular concentrations vary. We 
illustrate our approach with a simple example of cells in a fed-batch bioreactor, 
consuming substrates Mi and producing biomass X and products Mj (Figure 2.1).  
 
Figure 2.1. Interactions between cells and bioreactor. Schematic representation of major 
fluxes into cells in a bioreactor during a fed batch process. Substrates, represented by Mi, are 
consumed with specific rates ri either associated with growth, with specific rate ri,c, or independent of 
growth with specific rate ri,nc. Part of the growth associated consumption of Mi is  converted to 
products Mj with a specific rate rj,c. A fraction of Mj is produced not correlated with growth with 





In this context, both substrates and products are metabolites denoted as M. The 
extracellular substrate Mi can be consumed either in a growth associated manner - 
and hence the specific consumption rate of Mi is proportional to the specific growth 
rate µ - or independent of growth. Part of the substrate is directly incorporated into 
the biomass or consumed for the synthesis of it, some is converted to products or used 
for maintenance purposes. Similarly, product formation can either be coupled with 
growth (Luedeking and Piret 1959), characterized by rate rj,c, or independent from 
growth, described by rj,nc. A mass balance of substrate Mi in the reactor is described 




= 𝑭. 𝑪𝑭,𝑴𝒊 +  𝒓𝒊. 𝑪𝑿𝑹𝑽𝑹       (2.1) 
 
The substrate consumption rate, ri is split into two parts as shown in Figure, a growth 
associated one, ri,c and one not correlated with growth, ri,nc. 
 
𝒓𝒊 = 𝒓𝒊,𝒄 + 𝒓𝒊,𝒏𝒄 = −𝒀𝑴𝒊
𝑿⁄
. 𝝁 + 𝒓𝒊,𝒏𝒄       (2.2) 
 
For product formation we get 
 
𝒓𝒋 = 𝒓𝒋,𝒄 + 𝒓𝒋,𝒏𝒄 = 𝒀𝑴𝒋
𝑿⁄
. 𝝁 + 𝒓𝒋,𝒏𝒄       (2.3) 
 
With variables: CF,Mi = concentration of substrate Mi in the feed (mol/L);  CMi = 
concentration of substrate Mi in the bioreactor (mol/L); CXR = viable cell density 
(cell/L); VR = reactor volume (L); 𝒀𝑴𝒊
𝑿⁄
= biomass yield coefficient (mol Mi / cell); µ = 




(cell·day); 𝑭 = feed flow rate (L/day); X indicates biomass associated variables and 
indices c and nc indicate processes coupled and not coupled to growth, respectively. 
The rates of substrate consumption, ri, and product formation, rj, are both calculated 
from experimental data by rearranging Equation 2.1: 
 






       (2.4) 
 
The derivative was computed by dividing the change of total quantity of metabolite 
Mi in a defined period divided by the length of the respective period. 





] = 𝑹 = 𝑨. 𝝁 + 𝑩 = [
𝒂𝒊
𝒂𝒋
] . 𝝁 + [
𝒃𝒊
𝒃𝒋
]       (2.5) 
 
where R, A and B are vectors with A and B constant within each metabolic phase. 
As a practical consequence, the specific production rate of each metabolite can be 
expressed as a function of the growth rate by using joined linear sub-models 
corresponding to distinct metabolic phases. The breakpoints between each sub-model 
correspond to metabolic shifts. 
2.3.2. Data Cleaning and Outlier Identification 
As experimental data contain errors that may corrupt the conclusions, outliers must 
be identified. In particular, at low viable cell density during culture startup, 
computed specific production rates are inherently noisy and make interpretation of 
cell metabolism difficult. We thus identified outliers on the first days of production. 
For each day from day 0 to day 2, data of all experiments was pooled since the 
conditions were identical until the feed addition started on fay 3 then principal 
components analysis (PCA) was performed on all the specific production rates of all 




Panaretos et al. 2005). The multidimensional distance from a sample point to its 
sample mean was then estimated using the T² Hoteling distance (Mason 1997, 
Bersimis, Panaretos et al. 2005). Values that fall outside an upper control limit 
(UCLT²) are defined as outliers assuming the data follows a multidimensional normal 













        (2.6) 
 
where 
n = number of observations 

















This scheme is iterated until no more outliers are identified (Figure 2.2).  
 
On the top of that outlier identification with PCA between day 0 and day 2, two 
constraints were added for later data points: 
1. All the data with viability below 50%, that were usually only observed in later 
culture phases, were removed from the dataset as low cell viability can also lead 
to biased and incorrect estimation of the specific production rates of metabolites.  
2. Data points with depletion of metabolites during a time period of interest were 
also removed from the dataset as the computation of the specific production rate 







Figure 2.2. Schematic representation of the data cleaning process. A principal component 
analysis (PCA) is performed, for each day from day 0 to 2 separately, on a pool of the specific 
production rates of all metabolites . The T² Hotelling distance (Mason 1997, Bersimis, Panaretos 
et al. 2005) is then computed by assuming a multi-normal distribution for the data. A simple 
statistical process control (SPC) (Mason 1997, Bersimis, Panaretos et al. 2005) is then used on 
these T² values to identify possible outliers. This scheme is repeated until no more outlier is 
identified. UCL: upper control limit. This methodology has been used on day 0, 1 and 2 of the cell 
cultivation since the experimental conditions are similar before the feeding starts on day 3. 
 
2.3.3. Identification of the Number of Metabolic Phases  
To avoid over fitting with the segmented regression, the number of phases has to be 
determined. Based on the metabolic-steady state paradigm, we assume that the 
vectors A and B (Equation 2.5) are constant within a metabolic phase. We can 
estimate coefficients A for all metabolites for the whole cell culture process by taking 









Vector A is assumed constant within each metabolic phase. As the derivative can 
amplify possible biological and analytical errors, the specific production rates were, 
preliminarily to deriving, smoothed as a function of the specific growth rate with the 
linear Locally Weighted Scatterplot Smoother (LOWESS) method (Cleveland 1979) 
by using SAS software JMP 11 ©. The LOWESS method represents non-parametric 
statistics that do not require any specific model. We used a “tricube” function 
(Cleveland 1979) as a weight function and for each fitted value, a fraction of the data 
points of 0.5 was used for the computation. The weight function W is defined as: 
 
 𝑾(𝒙) = {(𝟏 −
|𝒙|𝟑)𝟑      𝒇𝒐𝒓 |𝒙| < 𝟏
𝟎                     𝒐𝒕𝒉𝒆𝒓𝒘𝒊𝒔𝒆
      (2.8) 
 
The derivatives of the LOWESS function is then also computed with JMP 11 ©. The 
recursive partitioning (Gaudard, Ramsey et al. 2006) is then used on the smoothed 
derivatives defined in Equation 2.7: the data is successively partitioned according to 
a splitting value for a given factor. The splitting value is the one that maximize the –
log(p-value), also called logworth, of the chi-square test measuring how different data 
is between the two partitions. The purpose of partitioning is to split all derivatives 
dR/dµ of each metabolite (Equation 2.7), as a function of the specific growth rate and 
then to determine the number of breakpoints. On the dataset of all breakpoints for 
all metabolites, we apply a hierarchical clustering to identify similar set of breakpoint 
values (Mojena 1977, Murtagh 1983, Szekely and Rizzo 2005) (Figure 2.3). Each 
observation starts in its own cluster, and at each step the clustering process 
calculates the distance between each cluster, and combines the two clusters that are 
closest together (agglomerative procedure). The agglomerative procedure is Ward’s 
method (Murtagh 1983). The linkage distance is defined as the “cost” in between-class 




the first "knee" point in the linkage function, i.e. the peak in the second-order 
derivative of the linkage distance function. The outcome is a first estimation of the 
breakpoint value of each metabolic phase and the total number of metabolic phases. 
2.3.4. Segmented Linear Regression 
Linear segments between all specific metabolic rates with the specific growth rate, µ, 
were identified using segmented linear regression analysis (McGee and Carleton 
1970, Toms and Lesperance 2003, Ryan, Porth et al. 2007). It is a regression model 
composed of a sequence of joined linear sub-models. If we define rk as the observed 
specific production rate of metabolite Mk and µ as the growth rate, we have, for n≥2 
metabolic phases and n-1 breakpoints BP𝒔 such that s∈{1,…,n-1}: 
 
𝒓𝒌(𝝁) = 𝒂𝒌,𝟏 ∗ 𝝁+𝒃𝒌,𝟏+ ∑ 𝒂𝒌,𝒔+𝟏 ∗ (𝝁 − 𝑩𝑷𝒋) ∗ 𝒖𝒔
n-1
s=1      
𝒖𝒔 = {
𝟏                𝒇𝒐𝒓 𝝁 ≤ 𝑩𝑷𝒔
𝟎                𝒇𝒐𝒓 𝝁 > 𝑩𝑷𝒔
     𝟏 ≤ 𝒔 ≤ 𝒏 − 𝟏    (2.9) 
 
bi,1, ai,1, ai,j+1 and BPj constant coefficients of metabolite Mi, for j∈{1,…,n-1}. 
This expression allows the regression function to be continuous at the breakpoint 
(Ryan, Porth et al. 2007). Amino acid limitation in the medium can lead to its 
depletion that would impact mAb and protein synthesis (Kilberg, Shan et al. 2009, 
Gramer 2014). As an extra constraint imposed to our model, as soon as an essential 
amino acid is depleted, the specific mAb productivity predicted by the model is set to 
zero. We consider tryptophan, histidine, isoleucine, methionine, threonine, 
phenylalanine, valine, tyrosine, leucine, lysine, glutamine, arginine and cysteine as 





Figure 2.3. Identification of the number of metabolic phase breakpoints. Hierarchical 
clustering was performed on the vector containing the breakpoint growth rate values identified from 
recursive partitioning. Each observation/breakpoint starts in its own cluster, and at each step the 
clustering process calculates the distance between each other cluster, and combines the two clusters 
that are closest together (Agglomerative procedure) (Murtagh 1983). The agglomerative procedure 
uses the Ward’s method to calculate the distance between each cluster. The objective was to identify 
the number of distinct metabolic phase breakpoints required to calibrate the segmented regression 
model (Figure 2.4). Two groups of breakpoints were identified, which correspond to two metabolic 
phase breakpoints BP1 and BP2. BP1= 0.54 ± 0.06 day-1; BP2=-0.08 ± 0.06 day-1. 
 
2.3.5. Parameter Estimation 
For each metabolite, based on the number n of metabolic phases determined by the 
hierarchical clustering, n models were set up from zero to n-1 breakpoints. For each 




square minimization (Wagner, Soumerai et al. 2002). To assess if the addition of a 
breakpoint makes the model prediction statistically superior to a model with a lower 
number of breakpoint, an F-test was performed at 95% confidence level. To alleviate 
the selection of too close breakpoints, a criterion has been added to the model: 
 
|𝑩𝑷𝟏 − 𝑩𝑷𝟐| > 𝟎. 𝟐 𝒅𝒂𝒚
−𝟏        (2.10) 
 
A summary of the methodology is presented in Figure 2.4. All estimations were 
carried out using EXCEL (Microsoft) for primary data treatment and Matlab Release 
2013a (The Mathworks, Natick, MA, USA) for further calculations unless otherwise 
stated. MATLAB scripts are supplied as Supplementary Material to automatically 
carry out segmented linear regression using a supplied data set. 
 
2.4.     Material and Methods 
2.4.1. Cell Line, Cell Cultivation, Sampling and Rate Estimations 
A CHO-DG44 cell line was used. The cells were cultivated in a proprietary chemically 
defined serum free medium in 2 L stirred tank glass bioreactor (STR) with supply 
towers (C-DCUII, Sartorius Stedim Biotech) controlled by a multi-fermentation 
control system (MFCS, Sartorius Stedim Biotech). The reactors were equipped with 





Figure 2.4. Developed methodology to identify and characterize metabolic phases. 
Experimental data are first cleaned using the methodology presented in Figure 2.2 and additionally 
by removing data with a viability below 50% or a depletion of metabolites during a measurement 
interval. The number of metabolic phases during the cell culture process are determined by 
differentiating the smoothed (LOWESS) reaction rates of all metabolites with respect to the growth 
rate (dR/dµ). Recursive partitioning is then applied on those derivatives to get a vector of possible 
metabolic phase breakpoints. Hierarchical clustering is then applied on this vector of possible 
breakpoints to define the number of final metabolic phases (clusters). Knowing the number of 
metabolic phases, the segmented regression can then be calibrated on the calibration dataset for 
each metabolite and validated on the cross validation dataset of the 2 L bioreactor and also of the 
2000 L bioreactor. 
The cultivation start volume was adapted to ensure an optimal cultivation end 
volume. The production bioreactors were seeded at similar target seeding density 




concentration (pO2) was set to 40% air saturation. To control pO2, air, nitrogen and 
oxygen were sparged into the culture using a cascade controller with a predefined 
mixture profile. The temperature was controlled at 36.8 °C.  
The culture was operated in fed-batch mode for 14 days. During the feeding phase, 
the monoclonal antibody (mAb) is secreted into the medium. Samples were drawn 
daily to determine total and viable cell number, viability, off-line pH, partial pressure 
of CO2, pCO2, osmolality, glucose-lactate, amino acid and mAb concentrations (stored 
at -80 °C). Antifoam was added manually on demand every day to control the build-
up of foam. 72 hours after inoculation, continuous nutrient feeding , i.e. constant feed 
rate specific for each day, was started with a predetermined rate using a proprietary 
chemically defined concentrated feed. In addition to that proprietary chemically 
defined concentrated feed  addition,. a glucose solution of 500g/L was added as a bolus 
to the culture when the glucose concentration dropped below 6 g/L but only from day 
6 onwards so that in the experimental conditions tested, glucose was never depleted 
at any time during the culture.. Samples for the amino acid analysis were taken 
before the feed addition. The extracellular concentrations after feeding were 
computed based on the feed composition information. Specific growth rate, μ, was 
computed for each experimental condition separately as the slope of the linear trend 
line obtained by plotting ln(CXR.VR) against time (Clarke, Doolan et al. 2011, Chin, 
Chin et al. 2015).  
2.4.2. Experimental Conditions 
Various feed compositions of amino acid were tested in small scale bioreactors (2 L) 
for a total of 29 experimental conditions. We varied the concentration of three 
different amino acids (aa1, aa2, aa3) contained in our feed as described in the 
Supplementary Table S2.1. 
The volume of feed added per bioreactor volume in the STR was the same in each 
condition. pH, temperature, stirrer speed and all the bioreactor parameters were 
controlled at the same value. The TSD was also the same for all experiments. Three 




addition profiles and chemically defined feed composition (Table S2.1), were also 
performed. The temperature set point, pH set point, pO2 set point, target seeding 
density, medium formulation, nutrient feed formulation, feeding strategy, and 
culture duration were the same as the 2 L bioreactor scale. 
2.4.3. Analytical Methods  
Cells were counted by using a VI-CELL® XR (Beckman-Coulter, Inc., Brea, CA) 
automated cell counting device that applied the trypan blue exclusion method. 
Glucose and lactate levels in the culture medium were determined using a NOVA 400 
BioProfile automated analyzer (Nova Biomedical, Waltham, MA). A model 2020 
freezing-point osmometer (Advanced Instruments, Inc., Norwood, MA) was used for 
osmolality determination. Offline gas and pH measurements were performed with a 
BioProfile pHOx® blood gas analyzer (Nova Biomedical Corporation, Waltham, MA). 
Product titer analysis was performed with a ForteBio Octet model analyzer (ForteBio, 
Inc., Menlo Park, CA) or protein A high performance liquid chromatography (HPLC) 
with cell culture supernatant samples which were stored at -80°C prior to analysis. 
Amino acids were analyzed by reversed-phase UPLC (Waters AccQ·Tagultra method) 
after ultra-filtration using Amicon Ultra-0.5 mL centrifugal filters (Merck Millipore, 
Billerica, MA). Statistical analysis were performed using SAS software JMP 11 ©. 
Matlab Release 2013a (The Mathworks, Natick, MA, USA) was used to calibrate the 
segmented linear model.  
 
2.5.     Results and Discussion 
The growth profile of all experimental conditions is depicted in Figure 2.5a. The 
growth behavior varies with the experimental conditions. For further analysis, we 
computed the specific production rates, ri, of glucose, lactate, ammonia, all amino 




2.5.1. Data Cleaning and Determination of the Number of 
Metabolic Phases 
We applied the outlier identification methodology based on the PCA on our dataset 
for days 0, 1 and 2 separately. From a total of 404 data points, 86 data points are from 
days 0, 1 and 2. From these 47 outliers were identified by using PCA and removed 
from the dataset. Based on the two extra constraints added to our data cleaning 
procedure from day 3 to day 14, data points with depletion of metabolites and/or with 
viability lower than 50% throughout the cell culture production were also removed 
from the dataset resulting in a total of 215 remaining data points.  
 
Figure 2.5. Experimental viable cell count and time course of specific growth rates. (a) 
Growth profiles of CHO-DG44 for 29 experimental conditions (see supplementary Table S2.1) with 
various cell growth behaviors. The cells were cultivated in a 2 L bioreactor operated in fed-batch 
mode for 14 days. Black arrow: Start of nutrient feeding with a predetermined rate. (b) Specific 
growth rate of the 29 experimental conditions after data cleaning (Figure 2.2) for the calibration 





This cleaned dataset was partitioned into two datasets based on the growth rate 
profiles of each experimental condition: 115 data points (calibration dataset) with a 
wide range of experimental conditions as specified in the Supplementary Table S2.1 
and 100 data points (cross validation dataset) with similar experimental conditions. 
The cross validation dataset contains experimental conditions within the design 
space of the calibration dataset. From the calibration dataset, two distinct clusters, 
which correspond to the breakpoints,  were identified based on recursive partitioning 
and hierarchical clustering as described above (Figure 2.3): one (Bp1) at a growth rate 
of 0.54 ± 0.06 day-1 and a second one (Bp2) at -0.08 ± 0.06 day-1. The first breakpoint 
was identified for all metabolites. The second breakpoint was only identified for 
proline, valine, leucine, methionine, tyrosine, threonine, cysteine, asparagine, lysine, 
glutamate, lactate and mAb. Hence, to avoid over fitting during the calibration of the 
segmented linear regression, the maximum number of breakpoints to identify was set 
to two.  
2.5.2. Calibration of the Prediction Model Using the Segmented 
Regression Model 
Segmented regression was applied on the cleaned calibration dataset, containing 
specific growth rates and not smoothed specific production rates of metabolites and 
mAb (Figure 2.6a). The identification of the metabolic phase breakpoints and the 
calibration of models were performed separately for each metabolite. Estimated 
model parameters are listed in Table 2.1. Twelve metabolites, i.e ammonium, glycine, 
alanine, methionine, serine, asparagine, glutamine, arginine, aspartate, glutamate, 
glucose and lactate, are impacted by metabolic phases. These metabolites are linked 
to glucose/glutamine metabolism and cell proliferation which confirms results of 
Rehberg et al.(Rehberg, Rath et al. 2014). Most models for these metabolites include 
only one breakpoint, i.e. only two metabolic phases were identified. Only glutamate, 
methionine and lactate have a specific production rate profile divided into three 




simple linear regression model and not impacted by metabolic phases: proline, 
isoleucine, leucine, lysine, valine, phenylalanine, cysteine, tyrosine, tryptophan, 
threonine, histidine and mAb (Figure 2.6a).  
2.5.3. Suitability of the Segmented Model to Identify Metabolic 
Phases 
Breakpoints were identified for 12 metabolites. For the 12 metabolites that have 
significant breakpoints,  the breakpoints Bp1 and/or Bp2 identified share similar 
values with a relative precision of breakpoint identification close to 5% for both 
breakpoints which supports the suitability of the method. The relative precision is 
defined here as the standard deviation divided by the range of the possible growth 
rate values.  
The first breakpoint between phases P1 and P2 was reached when the initially high 
specific growth rate, µ, decreased below a value of 0.58 ± 0.09 day-1, the second one 
between phases P2 and P3 when µ fell below -0.18 ± 0.09 day-1 (Figure b). The 
segmented linear regression identified breakpoint Bp1 for only 11 metabolites and 
breakpoint Bp2 for 4 metabolites (Table 2.1) which is less than those identified with 
the combination of recursive partitioning and hierarchical clustering. This may be 
explained by the sensitivity of the second method to outliers: the LOWESS regression 
may create additional trends that only exist due to possible outliers and the 
derivative computation can amplify the noise. Moreover, no F-test is performed with 
the combination of recursive partitioning and hierarchical clustering which could 
possibly identify non-significant metabolites. Nevertheless, breakpoints identified by 
both methods  are similar which proves the reliability of the segmented linear 
regression to identify metabolic phases. As a conclusion from our work, the 
application of segmented regression is sufficient to identify relevant breakpoints and 






Table 2.1. Segmented model coefficients. For each metabolites and for each metabolic phase, the 
value of coefficient a and b from Equation 2.5 is presented. The coefficients were also identified with 
the cross validation dataset and presented in the brackets. Red names correspond to metabolites 
that are impacted by the three metabolic phases. Bold names are metabolites that are impacted by 
two metabolic phases. Glc – glucose; Lac – lactate, mAb – monoclonal antibody 
 a (10-09 mmol/cell) b (10-09 mmol/[cell.day]) 
 P1 P2 P3 P1 P2 P3 
NH4+ 12.45 (9.90) -0.16 (-0.18) -7.81 (-6.10) 0.04 (0.04) 
Gly 2.04 (2.12) -0.002 (0.08) -1.07( -1.15) 0.02 (0.02) 
Ala 5.15 (4.78) -0.11 (0.02) -3.03 (-2.84) 0.02 (-0.02) 
Pro -0.05 (-0.10) -0.06 (-0.04) 
Val -0.06 (-0.13) -0.09 (-0.06) 
Leu -0.09 (-0.14) -0.12 (-0.08) 
Ile -0.07 (-0.03) -0.06 (-0.04) 
Met -0.46 (-0.57) -0.03 (-
0.006) 




Phe  -0.04 (-0.05)  -0.03 (-0.02) 
Tyr -0.00009 (-0.05) -0.06 (-0.03) 
Trp -0.009 (-0.012) -0.02 (-0.01) 
Ser -1.47 (-1.87) -0.08 (-0.17) 0.48 (0.14) -0.18 (-0.14) 
Thr -0.04 (-0.09) -0.07 (-0.05) 
Cys 0.01 (-0.06) -0.07 (-0.05) 
Asn -0.44 (-0.49) 0.78 (N/A) -0.25 (-0.17) -0.11 (N/A) 
Gln -12.39 (-
12.17) 
-0.03 (-0.06) 7.42 (7.38) 0.007 (0.007) 
Lys -0.10 (-0.20) -0.10 (-0.06) 
His -0.03 (-0.05) -0.01 (-0.009) 
Arg -3.14 (-0.72) -0.08 (-0.09) 2.19 (0.38) -0.03 (-0.03) 
Asp 1.97 (1.49) -0.02 (-0.02) -1.25 (-0.95) -0.05 (-0.05) 
Glu 1.84 (1.31) 0.07 (0.05) 1.20 (N/A) -1.19 (-0.85) -0.09 (-0.09) 0.18 (N/A) 
Glc -18.34 (-
18.58) 
-0.04 (-0.21) 9.61 (10.00) -0.98 (-0.88) 




0.03 (-0.06) -4.86 (N/A) 







Figure 2.6. Segmented regression of specific rates as a function of the growth rate. To 
identify metabolic phases, segmented regression was used (Figure 2.4). Data of the 2 L bioreactor 
calibration dataset were used. Three models were set up for each metabolite, from zero up to two 
breakpoints. To assess whether the addition of a breakpoint makes the model prediction statistically 
superior to a model with a lower number of breakpoints, an F-test was performed with 95% 
confidence level. (a) Segmented regression models are presented. Red names correspond to 
metabolites that are impacted by metabolic phases, i.e. which show better prediction with one to two 
breakpoints. When the segmented regression model is characterized by a red line, three metabolic 
phases were identified. Identification of two metabolic phases are characterized by a green line. (b) 
The twelve metabolites that were significantly impacted by metabolic phases are presented for each 
metabolic phase: P1, P2 and P3. Blue arrow: net uptake; Dark arrow: net secretion. The widths of 






The first metabolic phase P1, defined by a high growth rate, is characterized by a 
high production of ammonium, glycine, alanine, lactate, glutamate and aspartate and 
a high consumption of methionine, asparagine, arginine, serine, glucose and 
glutamine. This is a common metabolic profile observed in literature with suspension 
CHO cells also called overflow metabolism (Niu, Amribt et al. 2013, Wahrheit 2015) 
or exponential phase (Dorka, Fischer et al. 2009, Amribt, Niu et al. 2013, Meshram, 
Naderi et al. 2013). All the other amino acids are also consumed during this first 
metabolic phase but the rates are lower than those of the twelve metabolites impacted 
by metabolic phases. During phase P1, lactate is a byproduct of the glycolysis and 
high excretion of alanine is due to the conversion of pyruvate to alanine via the 
alanine aminotransferase (ALAT) serving as a nitrogen sink. Glycine synthesis is a 
result of high serine uptake which is generally observed for mammalian cells and can 
be linked to nucleotide synthesis and to cell proliferation (Narkewicz, Sauls et al. 
1996). Glutamine is taken up as a carbon source for the tricarboxylic acid cycle (TCA) 
cycle and hydrolyzed into glutamate and ammonium. Asparagine is partly converted 
into aspartate which can then be converted into oxaloacetate. In the second metabolic 
phase P2 (Figure 2.6b), the growth rate further decreased and some metabolites, i.e. 
ammonium, alanine, lactate, glutamate and aspartate, started being consumed. This 
metabolic phase is usually called balanced metabolism (Wahrheit, Niklas et al. 2014, 
Wahrheit 2015) or transition phase (Provost, Bastin et al. 2006, Naderi, Meshram et 
al. 2011, Zamorano, Vande Wouwer et al. 2013). Overall, the rates of all metabolites 
were lower than in phase P1. Alanine and lactate, accumulated during the phase P1, 
were converted back to pyruvate, which is a major characteristic of CHO cell 
metabolism. The last metabolic phase P3 (Figure 2.6b) is characterized by an 
accumulation of methionine, an increase of the consumption of glutamate and 
asparagine, and an overproduction of lactate. For the other eight metabolites that 
were impacted by the first metabolic shift, no break of slope could be observed 




called in the literature the maintenance phase (Yu, Hu et al. 2011, Wahrheit 2015) or 
death phase (Provost, Bastin et al. 2006, Zamorano, Vande Wouwer et al. 2013).  
Usually, different growth behaviors can be observed during process production, 
making it quite difficult to compare their metabolic characteristics by only using time. 
Using the growth rate rather than time allows better identification of metabolic 
phases and better comparison of their characteristics between various experimental 
conditions particularly in fed-batch cultivation.  
2.5.4. Validation of the Model at Small Scale (2 L) 
Metabolic profiles of the cross validation dataset were predicted (Figure 2.7) from the 
experimental growth rate of the cross validation dataset and parameters of 
segmented regression model identified using the calibration dataset (Table 2.1). Since 
the growth rates were overall similar in the cross validation dataset, the data can be 
presented as a function of time. The model prediction closely followed the 
experimental trends throughout the cell culture process. The only discrepancy 
occurred in the late stages, on day 13, for 18 metabolites. For 4 metabolites, i.e. 
tyrosine, tryptophan, cysteine and glucose, the prediction is also out of range for day 
12.  
2.5.5. Prediction of the specific production rate in large scale 
(2000 L) 
To estimate the transferability of the segmented regression model to a larger scale 
cultivation, specific production rates of metabolites of each 2000 L experiment were 
predicted (Figure 2.8) by the model estimated on the 2 L bioreactor calibration set 
(Table 2.1). As the growth rates were similar for the triplicate experimental 
conditions, the data could be presented together as a function of time. The prediction 
model is able to track the experimental trends of almost all metabolites over the 
entire culture period. Overall 88% of the predictions fall into a 3 standard deviations 
interval. Two amino acids, named aa1 and aa2, were depleted throughout the cell 






Figure 2.7. Cross validation of the segmented regression models for each metabolite in 2 L 
bioreactor runs. The specific production rates of all metabolites for the validation dataset are 
presented as a function of time (day) as the specific growth rate profiles were similar (Figure 2.5). 
The error bars correspond to 3 standard deviations. The prediction (red line) is based on the 
segmented regression of the calibration dataset (Figure 2.6) and used the experimental specific 
growth rate profile (Figure 2.5b) to estimate specific production rates. The prediction variability is 
due to the growth rate value variability and the error bars presented for the prediction correspond 
also to the 3 standard deviation. When the prediction was out of the 3 standard deviations range, the 






Figure 2.8. Validation of the segmented regression models for each metabolite at 2000 L 
bioreactor scale. The specific production rates of each metabolites for three 2000 L bioreactors 
runs with the same experimental condition are presented as a function of time (day) as the specific 
growth rate profiles are similar. The error bars correspond to 3 standard deviations. The prediction 
model (red line) is based on the segmented regression of the calibration dataset (Figure 6) and is 
based on the experimental specific growth rate profile (Figure 5b). The prediction variability is due 
to the growth rate value variability and the error bars presented for the prediction correspond also to 
the 3 standard deviation. When the prediction was out of the 3 standard deviations range, the 






Figure 2.9. Prediction of the final mAb titer and of aa1 and aa2 concentrations. (a) 
Experimental and predicted final mAb titers for the calibration dataset (2 L) and for large scale 
bioreactor runs (2000 L). The prediction is based on the segmented regression model of the specific 
productivity. The calibration dataset (2 L) and the large scale bioreactor runs (2000 L) are divided 
into 2 subsets: one without depletion of any metabolite during the cell culture process (No), and the 
other with depletions of aa1 and aa2, two amino acids, during the cell culture process (dp). The error 
bars correspond to 3 standard deviations for both prediction and experimental data. (b) Prediction of 
aa1 and aa2 concentrations before feeding during the whole cell culture process in triplicate 






2.5.6. Accuracy of the Segmented Model for Prediction of 
Metabolite Profiles (2 L and 2000 L) 
Cross validation of the segmented models showed good results for all metabolites. 
The ability to predict the experimental metabolite profiles in large scale experiments 
reinforces the validity of the model and justifies the initial assumption of linear 
correlation of specific rates of metabolites with the specific growth rate. The accuracy 
of our model with two to a maximum of six parameters to estimate for each metabolite 
is remarkable. For twelve metabolites, even if a simple linear model was used, the 
model has provided accurate results. Moreover, adding more parameters to the model 
may lead to over fitting. From this point of view, the model can be used for accurate 
prediction of the specific production rates of metabolites and so, of the metabolite 
concentrations, requiring only the experimental specific growth rate of the prevailing 
experiment. The established model would also allow online estimation of metabolic 
rates on the bases of online measured biomass parameters, e.g. viable cell count. It 
could therefore potentially also be applied for on line optimization of feeding profiles. 
2.5.7. Accuracy of the segmented model for prediction of final 
mAb titers (2 L and 2000 L) 
The model was used to predict the final mAb titer. Results of prediction model are 
presented in Figure 2.9a. The final mAb titer prediction in 2 L is accurate and within 
the range of ±3 standard deviations even for conditions with a depletion of 
metabolites throughout the cell culture process. Similarly to the small scale, the 2000 
L triplicate experimental conditions previously used to compare the metabolite 
prediction profiles were depleted in some metabolites, i.e. aa1 and aa2, during the 
cell cultivation. Hence, the prediction of the final mAb titer in 2000 L is also compared 
to other duplicates experimental conditions in 2000 L bioreactors runs without 
metabolites limitations throughout the cell culture process. The final mAb titer 




limitations throughout the cell culture process (Figure 2.9a). Our model is able to 
predict mAb titer decrease due to essential amino acid depletion. 
2.5.8. Prediction outside calibration experimental conditions. 
The segmented regression methodology was used to identified coefficients a and b 
from equation 2.10 with the cross validation dataset. The objective was to compare 
both coefficients identified with the cross validation dataset and with the calibration 
dataset. Results are presented in Table 2.1 in the brackets and in supplementary 
material (Figure S2.1). As expected, the breakpoints Bp2 was not identified with the 
cross validation dataset as the growth rates minimum values were higher than Bp2.  
For coefficients a and b within metabolic phase P1 and P2, coefficients are similar 
which prove the predictability and applicability of the methodology. As the cross 
validation dataset only contained 4 different experimental conditions, we can 
conclude from this work that the presented method does not require a wide range of 
different experimental conditions in order to set up a robust and predictive model. 
The question of the minimum of data points and experiments needed is difficult to 
answer, since it depends on the quality of the measured data.  
 
2.6.     Conclusion 
In summary, we propose an accurate predictive model of external metabolite rates 
which requires few parameters to estimate and seems very robust. The final titer can 
also be predicted even if the cells are starved in some metabolites. It should also be 
highlighted that an entire and complex metabolic network is not needed in order to 
achieve the macroscopic modeling which makes it simpler and, possibly, easily 
adaptable to other cell clones and cell lines. We also presented a systematic 
methodology to identify metabolic phases that allows comparing various 
experimental conditions with different growth behavior. It provides an excellent basis 




showed that the metabolites that are more impacted by metabolic shift are those 





3 Predictive Macroscopic Modeling of Cell 
Growth, Metabolism and Monoclonal Antibody 
Production: Case Study of a CHO Fed-batch 
Production 
3.1.     Abstract 
We describe a systematic approach to establish predictive models of CHO cell growth 
during biopharmaceutical production. Cell growth, cell metabolism and monoclonal 
antibody (mAb) production are predicted by combining an empirical metabolic model 
with mixed Monod-inhibition type kinetic that we generalized to every possible 
external metabolite. We describe the maximum specific growth rate as a function of 
the integral viable cell density (IVCD). Moreover, we also take into account the 
accumulation of intracellular metabolite pools that can influence cell growth. This is 
illustrated with fed-batch cultures of Chinese Hamster Ovary (CHO) cells producing 
a mAb. The impact of two selected essential metabolites on cell growth and cell 
productivity was assessed and the macroscopic model was successfully used to predict 
the impact of new untested feeding strategies on cell growth and mAb production. 
The resulting model combining piecewise linear relationships between metabolic 
rates and the growth rate and Monod-inhibition type models for cell growth did well 
predict cell culture performance in fed-batch cultures even outside the range of 
experimental data used for establishing the model. 
 
This chapter is in preparation for submission 
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3.2.     Introduction 
Determination of the optimal nutrients conditions throughout the bioreactor 
production step is essential to reach high productivity and product quality. Currently 
it relies on numerous time-consuming and costly experiments. Predictive models 
could help reduce the need for expensive experiments and accelerate bioprocess 
development. Various attempts have been made in the past to characterize these 
processes by mathematical models (Ben Yahia et al., 2015; Klein et al., 2015; Niu et 
al., 2013; Nolan and Lee, 2012). However, throughout the bioreactor production, the 
cells adapt to the changing extracellular conditions resulting in the development of 
different metabolic phases and related metabolic shifts (Ben Yahia et al., 2016; Ben 
Yahia et al., 2015; Dean and Reddy, 2013; Farzan et al., 2016; Nicolae et al., 2014; 
Niklas et al., 2013; Wahrheit, 2015; Wahrheit et al., 2014a; Wahrheit et al., 2014b). 
The metabolic and regulatory processes underlying such metabolic shifts remain 
largely unknown. Integrating principles developed in the metabolic engineering field 
might improve such modeling. We previously developed a systematic approach to 
identify metabolic phases and obtain an accurate stoichiometric model of cells 
metabolism during CHO fed-batch culture (Ben Yahia et al., 2016). We also 
demonstrated that the model developed at small scale remains correct upon scale up. 
This purely stoichiometric model does not require any a priori metabolic network 
information and describes metabolic changes as a function of the specific growth rate 
that can be obtained experimentally. Nevertheless, it also does not take into account 
any inhibitory impact of high metabolite concentrations or of metabolite depletion on 
cell culture performances. Moreover, a predictive kinetic model of the cell growth and 
associated metabolic activities is needed as the input of the previously developed 
model in order to develop an in silico predictive model. In this paper we provide a 
generalized methodology for prediction of cell growth based on the Monod type 
kinetics combined with substrate inhibition building on previous work (Amribt et al., 
2013; Ben Yahia et al., 2015; Farzan et al., 2016; Nolan and Lee, 2012). This model 




metabolism and production of mAb. We apply it to a case study of a fed-batch cell 
culture production of a mAb with CHO cells. Such macroscopic models rely on the 
category of so-called “unstructured models” (Ben Yahia et al., 2015; Borchers et al., 
2013; Dhir et al., 2000; García Münzer et al., 2015). A difference from the common 
Monod type model is the assumption of non-constant maximum specific growth rate 
which is assumed to be function of the integral viable cell density (IVCD). We also 
provide insights into the predictive power of simple model structures with regard to 
the impact of untested feeding strategies on recombinant protein production 
performance in fed-batch culture. 
 
3.3.     Modeling and theoretical aspects 
3.3.1. Step 1 : Calibration of the maximum specific growth rate 
observed 
For modeling of mammalian cell culture kinetics, the Monod equation and derivatives 
are most frequently applied (Amribt et al., 2013; Ben Yahia et al., 2015; Farzan et 
al., 2016; Nolan and Lee, 2012). Indeed when slightly modified, this formalism 
enables the prediction of a wide range of characteristics such as saturation, 
inhibition, and limitation by substrates and other components. Hence we apply this 
approach to predict cell growth without using any complex parameter calibration.  
The growth rate is defined as a function of the maximum specific growth rate, µmax, 
and of selected metabolite concentrations to simulate limitation and inhibition 
effects. However, generally µmax is defined as constant (Amribt et al., 2013; Ben Yahia 
et al., 2015; Farzan et al., 2016; Nolan and Lee, 2012). This does however not describe 
the observed decrease of the maximum specific growth rate throughout a cell culture 
production even if optimal experimental conditions are maintained (Borchers et al., 
2013; Lee, 2002). We propose the following equation to simulate the maximum 
specific growth rate which may be caused by the inhibitory effect of an undefined 






𝝁𝒎𝒂𝒙(𝒐𝒃𝒔) = 𝝁𝒎𝒂𝒙 − 𝜶𝑰 ∗ 𝑰
𝜷𝑰




         (3.1) 
 
where: µmax  - maximum specific growth rate (1/day), µmax(obs)  - maximum specific 
growth rate observed (1/day), IVCD - cumulative integral viable cell density 
(cell.day/mL), VCD - Viable cell density (cell/mL), I - undefined inhibitory component 
produced by cells (mg/mL), αI  - constant inhibitory rate of component I (mLβI 
/[mgβI.day]), βI  - constant index for inhibitory effect, a  - constant specific production 
rate of inhibitory component I (mg/[cell.day]).  
 
As we don’t exactly know which inhibitory component is produced by the cells, the 
IVCD was used as an indicator:  
 
𝝁𝒎𝒂𝒙(𝒐𝒃𝒔) = 𝝁𝒎𝒂𝒙 − 𝜶 ∗ 𝑰𝑽𝑪𝑫
𝜷𝑰         (3.2) 
 
where α  - constant inhibitory rate of IVCD equal to a*αI (mLβI/[mgβI-1.cell.day²]). 
 
3.3.2. Step 2 : Calibration of the generalized model of specific 
growth rate 
The depletion of any essential metabolite but also high concentrations of such 
metabolites limit cell growth. Here we consider for instance the amino acids 
tryptophan, histidine, isoleucine, methionine, threonine, phenylalanine, valine, 
tyrosine, leucine, lysine, glutamine, arginine and cysteine as essential metabolites 
(Hu and Zhou, 2012). The generalized model of specific growth rate µ is expressed as 














𝒊=𝟏        𝒊𝒇 𝝁𝒎𝒂𝒙(𝒐𝒃𝒔) > 𝟎 
  
− 𝝁𝑫                                               𝒆𝒍𝒔𝒆
   (3.3) 
 
 
Where, n – number of metabolites, Mi  - concentration of essential metabolite i 
(mg/mL), Ki  - half saturation constant of metabolite i (mg/mL), KIi  - inhibition 
constant of metabolite i (mg/mL) and µD  - specific death rate (day-1). 
 
When the cells reach an IVCD that leads to a negative maximum specific growth rate 
observed defined by equation 3.2, the specific growth rate is then defined as equal to 
the specific death rate µD which is assumed to be constant.  
 
3.3.3. Step 3 : Calibration of the cell metabolism and the specific 
productivity model 
As the specific growth rate depends on the concentration of essential metabolites Mi, 
the production rates of these metabolites have to be predicted within each metabolic 
phase in which the pseudo steady state approximation is verified. The specific 
conversion rates of these metabolites can be expressed as follows (Ben Yahia et al., 
2017): 
 
𝒓𝑴𝒊 = 𝒂𝒊 ∗ 𝝁 + 𝒃𝒊       ∀𝒊 ∈ [𝟏, 𝒏]                (3.4) 
 
Where: rMi  - specific production rate of metabolite i (mg/[cell.day]), ai  - parameter for 
metabolite i production dependent on growth (mg/cell) and bi  - parameter for 
metabolite i production independent on growth (mg/[cell.day]). ai and bi are constant 
within each metabolic phase identified according to the method from Ben Yahia et al. 




Similarly, in each metabolic phase, the specific productivity of the mAb is defined as 
linearly dependent on the specific growth rate as follow: 
 
𝑸𝒑 𝒎𝒂𝒙 = 𝒂𝒎𝑨𝒃 ∗ 𝝁 + 𝒃𝒎𝑨𝑩        (3.5) 
 
Where: Qp max - specific production rate of mAb (mg/[cell.day]), amAb  - parameter for 
mAb production dependent on growth (mg/cell) and bmAb  - parameter for mAb 
production independent on growth (mg/cell). ai and bi are constant within each 
metabolic phase identified by Ben Yahia et al. (Ben Yahia et al., 2016). 
The parameters of these equations can be identified by segmented linear regression 
(Ben Yahia et al., 2016) 
Metabolites limitation in the medium can lead to their depletion. Such depletions can 
in turn impact mAb and protein synthesis (Gramer, 2014; Kilberg et al., 2009). 
Moreover, high concentration of essential metabolites can also lead to a decrease in 
specific productivity. To express these impacts, the specific productivity observed is 
defined as follows based on Monod type equations: 
 








𝒊=𝟏            (3.6) 
 
Where: Qp max  - specific production rate of mAb predicted by equation 3.5 
(mg/[cell.day]), Mi  - concentration of essential metabolite i (mg/mL), K’i  - half 






3.3.4. Step 4 : Prediction of an accumulation of intracellular 
metabolite 
Modeling of storage components can also be taken into account to extend kinetic 
models as described in  (Richelle and Bogaerts, 2015) and by the case study presented 
in this paper. If the cell growth model prediction does not fit with experimental data 
for conditions with depletion of a specific metabolite Mi, the model is updated by 
taking into account the hypothetic accumulation of intracellular metabolites related 
to metabolite Mi. We hypothesized that Mi is used for cell growth and mAb production 
and that Mi related components, called metabolite Mxi, accumulate as intracellular 
pool that can be used for growth when extracellular Mi is depleted. The accumulation 
rate of the intracellular Mxi pool is assumed to be equal to the constant parameter bi 
from equation 3.4 minus the rate of production of the mAb adjusted with mass 
fraction of Mi in the mAb sequence. The part of Mi used for cell growth is defined as 
ai*µ. When Mi is depleted, the specific productivity is equal to zero, as described in 
equation 3.6, and also rMi (Figure 3.1). This is formulated as follow: 
 
𝒓𝑴𝒙𝒊,𝒑𝒐𝒐𝒍 = 𝒓𝑴𝒊 − 𝒂𝒊 ∗ 𝝁 − 𝑸𝒑 ∗ 𝒙𝑴𝒊                                                            
   = 𝒃𝒊 − 𝑸𝒑 ∗ 𝒙𝑴𝒊                                                                 
  (3.7) 
 
Where 






Figure 3.1 Representation of the accumulation of intracellular Mxi pool in a cell. 
Metabolite i (Mi) is directly used for mAb production and partly converted into a metabolite Mxi 
denoted as Mxi,pool that can accumulate and further be used for cell growth. When extracellular Mi 
is depleted, the Mxi pool can still be consumed to allow cell growth. The accumulation of the 
intracellular pool is estimated using the segmented linear relationship between the specific 
production rate of Mi, rMi, and the specific growth rate, rMi=ai*μ+bi. The part not correlated to the 
cell growth, bi, is defined equal to the specific production rate of mAb adjusted to mass fraction of Mi 
in the mAb, i.e. xMi, and the rate of accumulation of Mxi pool. The part correlated to the cell growth, 
ai*μ, is the part of Mi eventually used for cell growth. 
Equation 3.3 is then modified to include the impact of intracellular Mxi pool on cell 














𝒊=𝟏      𝒊𝒇 𝝁𝒎𝒂𝒙(𝒐𝒃𝒔) > 𝟎
  
− 𝝁𝑫                                                                                        𝒆𝒍𝒔𝒆
    (3.8) 
 
Where: Mxj pool - intracellular metabolite Mxj pool related to metabolite Mj. It is 




A summary of the macroscopic modeling methodology is presented in Figure 3.2. 
 
Figure 3.2 Macroscopic modeling methodology. The methodology is separated into 3 mandatory 
steps and one facultative step. First the maximum specific growth rate model is calibrated with a 
control conditions with no depletion of metabolites and no inhibitory metabolite concentrations 
(based on literature). The generalized growth model from equation 3.3 is calibrated in step 2 and 
finally the cell metabolism model from equation 3.4 and 5 are calibrated using segmented linear 
regression (Ben Yahia et al., 2017) in step 3. Finally the cell growth, mAb titer and metabolite 
concentrations are compared to experimental data. If the growth prediction does not fit with 






3.4.     Case Study 
3.4.1. Objective 
The case study presented in this paper focuses on the fed-batch production of a mAb 
produced by Chinese Hamster Ovary (CHO) cells. The critical impact on growth and 
production of two metabolites present in the bioreactor during the production step 
were identified in previous experiments to have the largest influence on growth and 
mAb titer. In particular cell growth and mAb titer were reduced when the 
concentration of M1 and/or M2 in the feed was doubled compared to the condition with 
the original concentration of M1 and M2 in the feed (see supplementary Figure S3.1). 
The goal of this paper is to predict is the prediction of the impact of these two 
metabolites on cell growth, metabolism and mAb production thanks to a dynamic 
model that will enable scalable in silico optimization of the process.  
3.4.2. Macroscopic model 
Both metabolites M1 and M2 are known to highly impact cell growth. Based on the 
model theory presented in the paper, it is assumed that the depletion of these 
metabolites stop the cell growth and that high concentrations of those metabolites 
also inhibit cell growth. Starting from equation 3.3, the model is expressed as follows 















     𝒊𝒇 𝝁𝒎𝒂𝒙(𝒐𝒃𝒔) > 𝟎
   
− 𝝁𝑫                                                                                 𝒆𝒍𝒔𝒆
  (3.9) 
 
With 𝜇𝑚𝑎𝑥 (𝑜𝑏𝑠) defined in equation 3.2 (Step 1) and parameters K1 and K2 are preset 
to a low value (0.0001 mg/mL). KI1 and KI2 have to be identified using experimental 
data. 
As the specific growth rate is depending on the concentrations of M1 and M2, the 




any metabolite is defined by equation 3.4 using a segmented linear model (Step 3). In 
this case study, the relationship between both metabolites and the specific growth 
rate was found to be constant throughout the whole cultivation and we have then: 
 
{
𝒓𝑴𝟏 = 𝒂𝟏 ∗ 𝝁 + 𝒃𝟏
𝒓𝑴𝟐 = 𝒂𝟐 ∗ 𝝁 + 𝒃𝟐
              (3.10) 
 
With a1, a2, b1 and b2 parameters identified as described in Ben Yahia et al. (Ben 
Yahia et al., 2016). 
Based on equation 3.6 we also have: 
 












       (3.11) 
 
3.4.3. Material and methods 
A genetically modified mAb production cell line (CHO-DG44) was used. The cells were 
cultivated in 2 L stirred tank glass bioreactor (STR) with supply towers (C-DCUII, 
Sartorius Stedim Biotech) controlled by a multi-fermentation control system (MFCS, 
Sartorius Stedim Biotech) where pH, temperature, stirring speed, gas sparging and 
feed addition were controlled. 
The culture was operated in fed-batch mode for 14 days. During the feeding phase, 
the monoclonal antibody (mAb) is secreted into the medium. Samples were drawn 
daily to determine total and viable cell number, viability, off-line pH, the partial 
pressure of CO2, pCO2, osmolality, glucose lactate, amino acid and mAb 
concentrations (stored at -80 °C). Samples for the amino acid analysis were taken 
before the feed addition. The extracellular concentrations after feeding were 
computed based on the feed composition information. The specific growth rate, μ, was 




line obtained by plotting ln(VCD.VR) against time (Chin et al., 2015; Clarke et al., 
2011), where VR represents the bioreactor volume.  
3.4.4. Experimental conditions 
To identify the inhibitory parameters of the Monod type equations (Equations 3.9 and 
3.11), we assessed the impact of high concentrations of those metabolites M1 and M2. 
For that purpose, five experimental conditions with different bolus additions on day 
3 and one control condition (experimental condition 1) were designed (Table 3.1). The 
total quantity of M1 and M2 added throughout the cell culture production was the 
same for each experiment as the feed addition was adapted when bolus addition were 
performed. To adapt the feeding strategy, the metabolite added as a bolus on day 3 
was not added for the next days of production until the control condition reached the 
same total quantity added of the metabolite. Day 3 was selected based on preliminary 
screening experiments: cultures were run in a fed-batch mode in 250 mL shake flasks 
for 8 days, each with a bolus addition of medium with a high medium concentration 
of M1 of 0.8 g/L at different time points (supplementary Figure S3.2). 
The model calibrated with this data set was also cross validated with a wide range of 
historical experimental data where the composition of both metabolites M1 and M2 in 
the feed was varied (Table 3.2). 
 
Table 3.1 Experimental conditions to identify inhibitory parameters. The maximum medium 
concentration of two different metabolites (M1, M2) were varied. Bolus additions were performed on 






Maximum concentration of M1 
(mg/mL) 
Maximum concentration of M2 
(mg/mL) 
1 1 0.06 0.2 
2 2 0.06 0.6 
3 3 0.9 0.6 
4 4 0.48 0.38 
5 5 0.9 0.38 
6 6 0.9 0.2 
7 1 0.06 0.2 





Table 3.2  Experimental conditions to cross validate the model. The concentration of two 
different metabolites (M1, M2) contained in our feed were varied. They are presented as percentage of 
the maximum concentration tested. The model of cell growth (Equation 3.10), cell metabolism 
(Equation 3.8) and mAb production (Equation 3.11)  were used to predict cell culture performances of 
the experimental conditions. 
Experimental ID Experimental 
condition M1 (%) M2 (%) 
9 7 100 50 
10 8 10 50 
11 9 50 100 
12 10 50 10 
13 11 10 10 
14 12 50 50 
15 13 25 25 
16 14 20 50 
17 15 10 30 
18 16 10 50 
19 17 30 50 
20 18 30 10 
21 19 50 30 
 
3.4.5. Parameter identification 
For each steps of the modeling methodology presented in Figure 3.2, parameters were 
identified as described below. 
3.4.5.1. Parameter estimation for Step 1 
Parameters of equation 3.2 were identified by analyzing one control condition, i.e. 
experimental condition 1  (Table 3.1), using the Gauss-Newton method. We assumed 
that for that control condition, the specific growth rate observed daily corresponds to 
the maximum growth rate possible as no depletion of metabolites M1 and M2 was 
observed and also M1 and M2 maximum concentrations do not exceed inhibitory 




3.4.5.2. Parameter estimation for Step 2 
The specific death rate was identified by taking the mean of the negative specific 
growth rate values observed at the end of the culture of experimental condition 1 
(Table 3.1). Half saturation constants of equation 3.9 are preset to 0.00001 mg/mL, 
i.e. small enough to be effective on the growth rate and only close to depletion of the 
respective metabolites (Provost et al., 2006). In order to identify inhibitory 
parameters of equation 3.9, a response surface design of experiment (DoE) was 
established (Table 3.1). The input parameters were the maximum concentration of 
M1 and M2 on day 3. The inhibitory parameters were identified using the Gauss-
Newton method by assuming that the specific growth rate of the control condition, 
i.e. experimental conditions 1 (Table 3.1), are the maximum possible between day 3 
and day 4. .  
3.4.5.3. Parameter estimation for Step 3 
Parameters from equations 3.10 and 3.5 were previously identified using segmented 
linear regression (Ben Yahia et al., 2016). Inhibitory parameters of equation 3.11 
were identified based on experimental conditions described in Table 3.1 in the 
manner than the identification of inhibitory parameters of the generalized cell growth 
model (Equation 9). Half saturation constants of equation 3.11 are also preset to 
0.00001 mg/mL 
 
3.5.     Results  
Experimental conditions presented in Table 3.1 were performed and the impact on 





Figure 3.3 Impact of high concentration of M1 and M2 on cell growth. In (a), the impact of M1 
and M2 maximum concentration reached throughout the cell culture production, defined as Cmax,M1 
and Cmax,M2 respectively, on cell growth is depicted. The viable cell density profile is presented. Error 
bars correspond to one standard deviation. In (b), a contour plot of the effect of M1 and M2 maximum 
concentration throughout the cell culture production on the final integral viable cell density (IVCD) 
is depicted. 
 
3.5.1. Modeling of the maximum specific growth rate observed 
(Step 1) 
The control experiments, i.e. the experimental condition 1 in Table 3.1, was used to 




(Equation 3.2). Parameters µmax, α and βI were identified: 0.73 day-1, 2.19*10-6 
mL0.69/[mg-0.31.cell.day²] and 0.69 respectively (Figure 3.4b). 
 
Figure 3.4 Specific growth rate profile for control conditions. In (a), the specific growth rate 
profiles of control experimental conditions defined by experimental ID 1 in Table 3.1 are depicted as 
a function of time. In (b), the specific growth rate of control experimental conditions defined by 
experimental ID 1 in Table 3.1 is expressed as a function of the integral viable cell density IVCD. 
The maximum specific growth rate is assumed to be inhibited by IVCD with an effect due to possible 
inhibitory components produced by the cells. Parameters α and βI (Equation 3.2) were identified: 
2.19*10-6 mL0.69/[mg-0.31.cell.day²] and 0.69, respectively. 
 
3.5.2. Identification of cell growth inhibitory parameters of M1 and 
M2 (Step 2) 
Bolus addition were performed on day 3 in order to reach the maximum 




same in all experiments. The cell growth behavior is impacted by maximum 
concentration of M1 and M2 reached (Figure 3.3, Figure 3.5a).  
 
Figure 3.5 Dependence of specific growth rate and specific productivity on maximum 
concentrations of M1 and M2. In (a), the maximum concentration on day 3 of M1 and M2 , defined 
as Cmax,M1 and Cmax,M2 respectively, on the specific growth rate between day 3 and day 4 (µ(day 3)). In 
(b), Cmax,M1 and Cmax,M2 on the specific mAb productivity between day 3 and day 4 (Qp(day3)). 
 
The death of cells follows first order kinetics (Equation 3.9) that is shown by the 
constant specific death rate observed after day 9 of the cultures for experimental 
condition 1 (Figure 3.4a). The specific death rate was identified as 0.1 day-1. 
Parameters KI from equation 3.9 were identified by setting the control conditions, i.e. 




day 3 and day 4, i.e. 0.55 day-1. For each experimental conditions we defined the 
specific growth rate on day 3 as: 
 






             (3.12) 
 
Parameters were identified using Gauss-Newton algorithm. KI1 and KI2 were 
identified as 1.29 mg/mL and 14.3 mg/mL respectively. 
3.5.3. Identification of specific productivity inhibitory 
parameters of M1 and M2 (Step 3) 
The specific mAb productivity on day 3 is also impacted by maximum concentration 
of M1 and M2 reached (Figure 3.5b).  
High concentration of M1 seems to lead to a decrease of specific productivity of mAb 
(Figure 3.5b). Parameters KI1’ and KI2’ from equation 3.10 were identified by setting 
the specific production rate at control conditions, i.e. experimental conditions 1 
defined in Table 3.1, as the maximum specific productivity on day 3. For each 
experimental condition we defined the specific productivity of mAb on day 3 as: 
 
𝑸𝒑  (𝒅𝒂𝒚𝟑)







             (3.13) 
 
Parameters were identified using Gauss-Newton algorithm. KI’1 and KI’2 were 
initially set to 72300mg/mL and 2.12 mg/mL respectively. As KI’1 is very high, high 
concentrations of M1 are not inhibitory for specific productivity which confirms the 
observation of the contour plot in Figure 3.5b. Therefore, equation 3.11 can then be 
simplified to: 
 














Qp max is defined by equation 3.5. The parameters amab and bmab, but also a1,a2, b1 and 
b2, were earlier identified using segmented linear regression (Ben Yahia et al., 2016).  
3.5.4. Accumulation of intracellular metabolite (Step 4) 
Based on a first assessment of the predictive capacity of the calibrated cell growth 
model, the prediction of cell growth does not fit with experimental data for some 
experimental conditions with depletion of metabolite M1 (data not shown). As 
presented on step 4 of our modeling methodology (Figure 3.2), the model was updated 
based on equation 3.7. This is formulated as follow  
𝒓𝑴𝒙𝟏,𝒑𝒐𝒐𝒍 = 𝒓𝑴𝟏 − 𝒂𝟏 ∗ 𝝁 − 𝑸𝒑 ∗ 𝒙𝑴𝟏      
   = 𝒃𝟏 − 𝑸𝒑 ∗ 𝒙𝑴𝟏           
      (3.15) 
Where 
xM1 : mass fraction of M1 in mAb (mg/mg) 
In order to verify the hypothesis of an accumulation of a Mx1 pool, a special 
experiment was designed. Three experimental conditions with triplicates were 
performed with various concentration of M1 in the feed until day 5, i.e. 50%, 25% and 
10%, where 100% corresponds to the highest concentration of M1 in the feed tested. 
Then the cells were transferred into a medium in which M1 is absent. After that 
transfer, only a feed without M1 was used. The objective was to see if the cells could 
grow without M1 and, if this was the case, if they grow better when they were fed 
with a higher concentration of M1 previously. Experimental conditions are 
summarized in Table 3.3. 
Experiments at conditions depicted in Table 3.3 were performed. The IVCD is 
depicted in Figure 3.6 for each experimental condition. Before media exchange, all 
experiments showed similar IVCD. After media exchange, increasing the percentage 
of M1 in the feed before media exchange led to higher IVCD which supports the 





Table 3.1 Experimental conditions to test the hypothesis of an intracellular accumulation 
of a metabolite related to metabolite M1. The concentration of metabolite M1 contained in our 
feed were varied from day 3 to day 5 included. They are presented as percentage of the maximum 
concentration tested in experimental conditions presented in Table 3.2. On day 5, the cells were 
transferred into the inoculation media deprived of metabolite M1 (red arrow in Figure 3.6). After day 
5 the cells were only fed with a feed not containing any metabolite M1. 
Experimental ID Experimental 
condition M1 (%) 
22 20 50 
23 20 50 
24 20 50 
25 21 25 
26 21 25 
27 21 25 
28 22 10 
29 22 10 
30 22 10 
 
At experimental conditions with 25% and 10% M1 in the feed, M1 was depleted (data 
not shown) before media exchange but the duration of depletion was shorter using 
25% M1 in the feed. We assume that for condition with 10% M1 in the feed, the 
intracellular pool was highly consumed before media exchange which led to an even 
lower IVCD compared to 25% M1 in the feed. Finally, at the experimental condition 
with 50% M1 in the feed before media exchange, metabolite M1 was never depleted 
before media exchange. Therefore the intracellular metabolite Mx1 pool is assumed 
higher than at other experimental conditions. As a consequence of this the resulting 





Figure 3.6 Impact of percentage of M1 in the feed on cell growth after media deprived in 
M1 exchange. The integral viable cell density (ICVD) profiles is presented for three experimental 
conditions with various composition of M1 in the feed depicted in Table 3.3. On day 5, media was 
exchanged with a media depleted on metabolite M1 (red arrow and vertical line). 
 
A summary of the model representation and the corresponding parameters identified 
for this case study are presented in Table 3.4. 
3.5.5. Comparison with experimental data (Cross validation) 
The model was used to predict the impact of various concentrations of M1 and M2 in 
the feed on cell growth, mAb titer and M1 and M2 concentrations using a similar 
feeding strategy. Experimental conditions presented in Table 3.2 were not used to 
calibrate the model. Results are presented in Figures 3.7, 3.8, 3.9 and 3.10. We can 
observe that the cell growth predicted fits well with experimental data (Figure 3.7). 
High concentrations and also low concentrations of M1 in the feed lead to a reduced 
cell growth as predicted by the model. Experimental mAb titers from day 12 to day 
14 were compared with predicted ones (Figure 3.8). A correlation was observed 
(r²=0.846) with a small offset for low concentration. The model can predict final mAb 





Table 3.4 Model representations and corresponding parameters identified to predict the 
impact of two essential metabolites (M1 and M2). Model parameters where identified using data 
from experimental conditions presented in Table 3.1. The parameters of the metabolic model where 
identified by Ben Yahia et al. (Ben Yahia, Gourevitch et al. 2016). 














     𝒊𝒇 𝝁𝒎𝒂𝒙(𝒐𝒃𝒔) > 𝟎
  
− 𝝁𝑫                                                                                        𝒆𝒍𝒔𝒆
     
K1 = 0.0001 mg/mL 
K2 = 0.0001 mg/mL 
KI1 = 1.29 mg/mL  
KI2 = 14.32 mg/mL 
Parameter identification from Table 3.1 
𝝁𝒎𝒂𝒙(𝒐𝒃𝒔) = 𝝁𝒎𝒂𝒙 − 𝜶 ∗ 𝑰𝑽𝑪𝑪
𝜷𝑰 
µmax = 0.73 day-1 
α = 2.19*10-6 mL0.69/[mg-0.31.cell.day²] 
βI = 0.69 
Parameter identification from Table 3.1 










K’1 = 0.0001 mg/mL 
K’2 = 0.0001 mg/mL 
KI’2 = 2.12 mg/mL 
Parameter identification from Table 3.1 
𝑸𝒑 𝒎𝒂𝒙 = 𝒂𝒎𝑨𝒃 ∗ 𝝁 + 𝒃𝒎𝑨𝑩 
Parameter values taken from (Ben Yahia, 
Gourevitch et al. 2016) 
𝒓𝑴𝟏 = 𝒂𝟏 ∗ 𝝁 + 𝒃𝟏
𝒓𝑴𝟐 = 𝒂𝟐 ∗ 𝝁 + 𝒃𝟐
 
Parameter values taken from (Ben Yahia, 
Gourevitch et al. 2016) 
 
Finally, the concentrations of metabolite M1 and M2 were compared to those predicted 
(Figures 3.9 and 3.10). The model prediction closely followed the experimental trends 
throughout the cell culture process (Figures 3.9 and 3.10). Based on the metabolite 
profile (data not shown) we can observe that for experimental condition 7 (Table 3.1), 
M1 was depleted from day 6 to day 14 but no impact on the cell growth profile was 
observed which tend to supports our hypothesis that a metabolite pool related to M1 
is present within the cells and is used when needed. For the experimental conditions 




influence of M1 on cell growth is well predicted by taking into account the possible 
accumulation of an intracellular Mx1 pool.  
 
Figure 3.7 Comparison of experimental with predicted VCD. The model developed in the 
present research (Equations 3.2 and 3.10)  was used to predict the cell growth for experimental 
conditions at various M1 and M2 concentrations in the feed, expressed as a percentage of the 
maximum concentration tested (Table 3.2). The experimental conditions were not used to calibrate 
the model. The experimental cell growth profile (solid) is compared to predicted cell growth profile 
(dashed). 
 
To summarize, the model can be used to extrapolate to untested conditions and 
predict cell growth, metabolite concentrations of targeted metabolites and the mAb 
titer which supports the suitability of the method. One can highlight that even for 
some experimental conditions (Table 3.2), where concentrations of M2 were out of the 
range tested (Table 3.1), the prediction of the mAb titer, cell growth and metabolite 
concentrations were still accurate. This proves the predictive power of the model 






Figure 3.8 Comparison of experimental with predicted mAb titers (from day 12 to day 14). 
The model developed in the present research was used to predict the mAb production for 
experimental conditions with various M1 and M2 concentrations in the feed, expressed as a 
percentage of the maximum concentration tested (Table 3.2). The experimental conditions in Table 
3.1 were not used to calibrate the model. The experimental mAb titers from day 12 to day 14 are 







Figure 3.9 Comparison of experimental with predicted M1 concentrations. The model 
developed in the present research (Equation 3.8)  was used to predict the M1 concentrations for 
experimental conditions with various M1 concentrations in the feed, expressed as a percentage of the 
maximum concentration tested (Table 3.2). The experimental conditions were not used to calibrate 
the model. The experimental profile of M1 (solid) is compared to predicted M1 concentrations  
(dashed). Experimental metabolite concentrations were only available for experimental ID 2, 3, 4, 5, 





Figure 3.10 Comparison of experimental with predicted M2 concentrations. The model 
developed in the present research (Equation 3.8) was used to predict the M2 concentrations for 
experimental conditions with various M2 concentrations in the feed, expressed as a percentage of the 
maximum concentration tested (Table 3.2). The experimental conditions were not used to calibrate 
the model. The experimental profile of M2 (solid) is compared to predicted M2 concentrations  
(dashed). Experimental metabolites concentrations were only available for experimental ID 2, 3, 4, 5, 
6, 7 and 8. 
3.6.     Conclusion 
By combining a  stoichiometric metabolic model based on segmented linear regression 
presented in a previous paper (Ben Yahia, Gourevitch et al. 2016) and the cell growth 
model based on Monod type kinetics extended with substrate inhibition presented in 
this paper, it was possible to develop a simple macroscopic model of cell growth, 
metabolite concentrations and mAb titer. In total ten kinetic parameters were 
identified to calibrate the metabolic model, the specific productivity model and the 
cell growth model, respectively. A major difference compared to usual Monod type cell 




defined as a function of the IVCD due to possible inhibitory component accumulation. 
Moreover, another difference from the common Monod type model, is the assumption 
of accumulation of a specific metabolite in an intracellular pool that can be used for 
growth when extracellular metabolites are depleted. We highlight that the simple 
model represented in Figure 3.1 is not the only one able to explain the experimental 
observations. To estimate this metabolite accumulation, the segmented linear model 
was successfully used. By using this estimation of metabolite pool accumulation, we 
were able to predict under which conditions the depletion of metabolite M1 would 
impact cell growth. This approach is simple and does not require any complex 
analysis of intracellular metabolites. Finally, only few experimental conditions are 
needed to set up the model: i.e. only eight fed-batch cell cultures were performed with 
only six different experimental conditions. The model can be used to predict cell 
growth of untested experimental conditions with various feeding strategy of targeted 
metabolites. In our case study, the model was successfully used to describe the 
influence of the concentrations of two metabolites (M1 and M2) in the feed. If a simple 
model of the influence of these two metabolites on product quality attributes (PQA) 
would be developed, this macroscopic model would be able to predict in silico the 
impact of new experimental feeding strategies on cell culture performance and PQA. 
This is a first step towards reducing the number of bioreactor experiments required 
to control fed-batch processes for monoclonal antibody production and moving 
towards in silico simulations of the impact of process parameters on product yields 
and cell metabolism. This model can therefore be further used to predict the best 
feeding strategy in order to get a high mAb titer and most likely also good PQAs. We 
strongly believe that this modeling methodology can be applied and extended to any 
essential medium component. We also emphasize that presented simple model 






3.7.     Acknowledgements 
 
We gratefully acknowledge the excellent experimental support by the following 







4 Conclusion and outlook 
Chinese Ovary Hamster (CHO) are an indispensable tool for biotechnological 
production of biologics which is a multi-million business. Recently, the 
pharmaceutical industry is increasingly focusing on early drug development which 
comes with increasing constraints to accelerate process development, reduce costs 
and demonstrate a deep understanding of cell culture processes. However, the 
problem with cells in vivo is their enormous complexity. Despite the fact that CHO 
can be cultivated in various types of bioreactors applying sophisticated feeding 
strategies, we are still not able to characterize and control end to end all the behavior 
of these cells. Present industrial practices in developing cell culture processes still 
rely to a large extent on statistical planning of experiments and large series of time-
consuming culture development. Modern systems biology promises modeling of such 
processes on the basis of a system-wide understanding of cellular processes but, as 
cellular metabolism is composed of thousands of regulated metabolic reactions 
combined with complex production processes involving fed-batch cultures, the 
development of complex predictive models is very difficult and time consuming. 
Moreover, even with our large and increasing knowledge of metabolic networks, the 
present knowledge on these and on their impact on the production of biologics is still 
incomplete. This may be one of the reasons that truly predictive models based on 
detailed system biological model have to be shown to become successful. 
Nevertheless, as Voit described it in his book (Voit 2000), “the search for “exact laws” 
is futile” i.e. that all models are based on approximations that can be modified, 
improved and even rejected. From an industrial point of view, applicable predictive 
models are highly demanded in industry for the purpose of process optimization and 
control in order to reduce costs and to accelerate process development. To reach to 
this objective, the focus of the presented thesis was to develop a systematic 




industrial environment. The models developed are believed to identify the essence of 
the biological mechanism, which makes them relatively simple.     
In the present work, simple modeling tools are presented that can be applied to CHO 
cells to study and predict fed-batch cell culture performances. The simplicity of the 
modeling approach comes from the low number of parameters to identify but also to 
the mathematical tools used which are well known and established in the scientific 
community. In chapter 1 the steps are introduced that are commonly used in the 
literature to set up macroscopic models of cell growth and metabolism in mammalian 
cells. It was identified that there are generally three main steps: the first one is the 
identification of the input-output relationship. Then a kinetic model is defined in 
order to link the inputs with the outputs. Finally the model is calibrated and the 
model parameters are identified. This kind of formalism was applied during the 
journey to identify and develop a systematic procedure to generate predictive models.  
 
The first step of the work was to develop a predictive model of cell metabolism which 
was presented in chapter 2 and was based on a segmented linear model. The 
objective was first to establish stoichiometric empirical models using metabolite 
specific rates and knowledge from metabolic engineering field on the principle of 
metabolic network, e.g. the metabolic steady state paradigm. By using this paradigm, 
metabolic phases can be identified which simplifies the development of predictive 
models. The bioproduction process was split into metabolic phases within each the 
stoichiometric relationships between the specific conversion rates of all metabolites 
and specific growth rate are constant. A systematic procedure to set up this kind of 
model is presented. Following the formalism presented in chapter 1, the input and 
outputs selected were the specific growth rate and the specific conversion rates of 
metabolites, i.e. amino acids, ammonium, glucose, lactate and mAb, respectively. 
First of all, the specific metabolite rates were estimated from experimental data, i.e. 
time series of metabolites and product concentrations as well as viable cell number, 




computation of specific rate is highly sensitive to noise and outliers. To this end, a 
pre-cleaning of data, i.e.  the specific rates computed, was also developed and applied 
in order to identify and remove possible outliers from the analysis. The model used 
to identify the metabolic phases and the stoichiometric relationship between the 
specific rates of metabolites and the specific growth rates was a segmented linear 
model in order to take into account the metabolic phases that the cell undergo during 
the cell culture production. To the best of our knowledge, this is the first study that 
presents a simple segmented linear model structure to describe mAb production but 
also amino acids, glucose, lactate and ammonium metabolism. The experimental 
growth rates of small scale production processes (2 L) but also large scale (2000 L) 
were used to predict the specific metabolic rates. The results show that the model 
prediction of specific rates of metabolites based on only one variable, i.e. the 
experimental specific growth rate, was comparable to experimental data at small (2 
L) but also large scale (2000 L). Surprisingly, beside the simplicity of the model 
structure, the accuracy but also the predictability and scalability of the models have 
been successfully proven during this thesis. An entire and complex metabolic network 
model is not needed for this model which makes it easily accessible. Moreover, the 
model was able to predict the impact of the depletion of essential metabolites on the 
specific productivity. The successfully applied modeling structure supports the initial 
assumption that even if the inner cell metabolism is complex, the specific production 
rates of each metabolites can be represented with an eventually simple linear model. 
In addition, we observed that the metabolites that are impacted by metabolic phases 
are the one linked to glycolysis and TCA cycle metabolism and cell growth. This 
information can be used to fully adapt the feeding strategy of those specific 
metabolites as a function of the metabolic phase. This kind of methodology can 






The model was accurate and predictive at small but also large scale, but still needed 
experimental specific growth rate data to fully predict cell metabolism. In a next step 
in chapter 3 a fully predictive cell growth model was established by incorporating 
growth kinetics for the identified phases in order to improve our modeling procedure 
and get a complete in silico model of the bioprocesses. Following the formalism 
presented in chapter 1, the inputs and outputs selected for that step were all the 
essential metabolites concentrations and the specific growth rate, respectively. The 
kinetic model developed was based on Monod-type structure but with some 
modifications. The main change was the use of a non-constant maximum specific 
growth rate. The logic behind this extension is based on the observation that CHO 
cells, even if having the characteristics of proliferative/cancer cells, cannot grow 
indefinitely in fed-batch bioreactors. The hypothesis proposed was that there is a 
possible accumulation of an inhibitory by-product which is continuously produced by 
cells. As the cell culture medium is never replaced, the cells cannot grow indefinitely. 
The other observation supporting this hypothesis, is the fact that cells can grow for 
months in perfusion mode hypothetically due to the continuous dilution of the 
inhibitory component. In order to test the developed modeling procedure on a case 
study with CHO cells, two essential metabolites driving growth kinetics were 
identified based on historical data. With this simple model structure and with a 
minimum number of data to calibrate the model, a wide range of new experimental 
conditions and cell culture performances was predicted. Moreover, in our case study, 
in order to predict the cell growth, the impact of intracellular metabolites related to 
M1 that accumulate in the cell had to be integrated in the model structure. 
Experimental data supports that hypothesis. To predict the accumulation of those 
intracellular metabolites pool, the segmented linear model of cell metabolism was 
successfully used. Therefore, the cell metabolism model (chapter 2) can also be 
extended and used to predict the accumulation of metabolites in intracellular pools 
but the model prediction of the intracellular metabolite pools was not compared to 




The cell growth model (chapter 3) combined with the linear piecewise regression 
model of cell metabolism (chapter 2) allows us to get a complete in silico prediction 
of the impact of untested feeding strategies on cell culture performances. To 
summarize the modeling procedure, the piecewise linear model of cell metabolism is 
used to predict the specific rates of metabolites as a function of the specific growth 
rate and the stoichiometric coefficients identified for each metabolic phase. Then the 
metabolic concentrations are computed based on the predicted specific rates and on 
the feeding strategy. Finally the specific growth rate is predicted using the Monod 
type structure and the metabolic concentrations predicted in previous step. This cycle 
combining the piecewise linear model and the kinetic model of growth allows to 
predict in silico a complete fed-batch bioprocess. A simple model to predict product 
quality is also in development and, if combined to the cell metabolism and growth 
models, can be used to fully predict the impact of new experimental conditions on the 
main variables such as growth, metabolite concentrations, titer and even PQA.  
 
In summary, the key highlights of the methodologies described in this thesis are that 
systematic modeling methodologies were developed and validated that capture the 
essential features for prediction.  They are relatively easy to implement but are 
accurate enough for prediction and for model based optimization of cell culture 
bioprocesses. This thesis demonstrates what rich knowledge can be derived from high 
quality macroscopic experimental data, and then used to predict new experiments. 
However, the model structures developed in this thesis do not take into account any 
physicochemical parameter such as the temperature, oxidative stress or pH which 
make the current model prediction only applicable to similar physicochemical 
conditions where only the feeding strategy is modified. Nevertheless, it is envisioned 
that the systematic procedure presented in this thesis is portable to other cell lines 
but can also be combined with other models that incorporate the influence of pH, 
osmolality or any other physicochemical parameters. The models can also be 




control of metabolic activity, a more detailed model of protein synthesis, folding and 
secretion, metabolite transports into the cells but also into mitochondria or the 
incorporation of other omics data such as of proteomics and metabolomics. 
The spirit of this thesis was to develop a systematic procedure to get eventually 
simple predictive models of complex processes - cell metabolism, cell growth and 
product formation, but also of product quality attributes. The ambitious goal was 
driving the development of a unique platform for in silico process optimization. This 
plays an important role in refining and developing hypotheses that can then be tested 
experimentally which will eventually lead to the reduction of cost and wet lab work 
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7 Supplementary Material 
SUPPLEMENTARY MISCELLANEOUS RESEARCH 
Minimum number of dataset needed to calibrate the segmented linear 
model 
During the development methodology presented in chapter 3, one of the question 
that was raised was the minimum number of data needed to calibrate the cell 
metabolism model. 
The feasibility of such method with less number of datapoints has been assessed and 
the minimum number of dataset needed to calibrate this model has been identified 
but data were not presented in this thesis. The methodology used is described in 
Figure S1.  
 
Figure S1 Methodology used to identify minimum number of data points necessary for 
accurate segmented linear modeling of cell metabolism. CI: confidence interval; CV: 





The same calibration dataset used in chapter 3 (Table 3.1) was used for a total of  
115 datapoints. We focused on the specific production rate of glycine that has been 
randomly selected for the presented analysis from the set of metabolites that have 
shown more than one metabolic phase. From this dataset, subsets of 20, 30, 50, 80 
and 100 datapoints were randomly extracted 50 times each ones. Then, for each 
subset, we analyzed the percentage of datasets identifying two metabolic phases, the 
percentage of datasets identifying breakpoints within the confidence interval (CI) of 
the breakpoint reference and the coefficient of variation (CV) of the model parameters 
identified. The CI of the breakpoint reference was defined from the initial dataset of 
115 datapoints of the first breakpoint BP1 and corresponds to the interval 
[0.507;0.567]. Results are presented in Figure S2. In our case, with the amino acid 
analytical method and measurement analysis equipment used, 80 data points were 







Figure S2 Accuracy of the segmented linear model with increasing dataset size. In a the 
percentage of breakpoints value identified for each dataset and within the confidence of interval of 
the initial reference dataset i.e. [0.507;0.567] are depicted. In b, the percentage of datasets 
identifying two metabolic phases is depicted. Two metabolic phases correspond to the maximum 
number of phases identified with glycine with the initial reference dataset. In c, the coefficient of 
variation (CV) of parameters in phase P1 (cf. Chapter 2) of the segmented linear model is depicted as 
function of the number of datapoints used. 
This information can contribute to improve biopharmaceutical production as the 
number of datapoints used to calibrate the metabolic model developed in this thesis 
can be reduced. It can speed up model development with another cell clone, another 






Product quality attributes macroscopic predictive model 
In order to get the most complete in silico model that can provide guidance on how to 
improve cell culture processes for industrial purpose, a prediction model of product 
quality attributes (PQA) can be developed in order to improve the modeling 
methodology presented in this thesis. For that purpose, a simple and empiric linear 
model of PQA was developed ad multivariate data analysis was used to identified the 
metabolites that are linked to PQA (data not shown). The linear model  developed 
was used to predict new experimental condition (Figure S3). Results show promising 
results. 
 
Figure S3 Comparison of one experimental product quality attribute 1 (PQA1) with the 
model  prediction. The data were normalized with the highest value reached. PQAs can refer to 
aggregates, charge variants, misincorporation, glycosylation profiles, drug color, deamination, amino 












Figure S2.1. Comparison of segmented model coefficients. For each metabolite and for each 
metabolic phase, the values of coefficients a and b from Equation 5 were identified with the 





Figure. S3.1. Impact of metabolite M1 and M2 on cell growth and mAb titer. Two 
experimental conditions performed in 2 L bioreactors vessel are depicted. The concentration of two 
different metabolites (M1, M2) contained in the feed were varied. They are presented as percentage of 
the maximum concentration tested. a - viable cell density (VCD); b - mAb titer normalized to the 







Figure S3.2. Impact of the day of bolus addition of inhibitory metabolite M1 on cell 
growth. Fed-batch cultures were performed in 250 mL shake flasks for 8 days. In five different 
experiments, a bolus addition of metabolite M1 was performed on day 3, 4, 5, 6 or 7. The 
concentration of M1 in the cell culture medium after bolus addition was 0.8 g/L. Three experiments 
were made in a batch mode without addition of M1 (black curve in part a and red bar in part b of the 








Supplementary Table S2.1. Experimental conditions. The concentration of three different amino 
acids (aa1, aa2, aa3) contained in the feed that were varied. They are presented as percentage of the 
maximum concentration tested 
*Control condition 
Vessel Experimental ID Condition aa1 (%) aa2 (%) aa3 (%) Dataset 
2 L 01 
01 
25 50 25 Cross validation 
2 L 02 25 50 25 Cross validation 
2 L 03 25 50 25 Cross validation 
2 L 04 
02 
10 10 10 Calibration 
2 L 05 10 10 10 Calibration 
2 L 06 03 10 10 100 Calibration 
2 L 07 
04 
10 50 50 Calibration 
2 L 08 10 50 50 Calibration 
2 L 09 05 10 100 10 Calibration 
2 L 10 06 10 100 100 Calibration 
2 L 11 
07 
50 10 50 Calibration 
2 L 12 50 10 50 Calibration 
2 L 13 
08 
50 50 10 Cross validation 
2 L 14 50 50 10 Cross validation 
2 L* 15 
09 
50 50 50 Cross validation 
2 L* 16 50 50 50 Cross validation 
2 L* 17 50 50 50 Cross validation 
2 L* 18 50 50 50 Cross validation 
2 L* 19 50 50 50 Cross validation 
2 L* 20 50 50 50 Cross validation 
2 L* 21 50 50 50 Cross validation 
2 L* 22 50 50 50 Cross validation 
2 L 23 10 100 10 10 Calibration 
2 L 24 11 100 10 100 Calibration 
2 L 25 
12 
100 50 50 Cross validation 
2 L 26 100 50 50 Cross validation 
2 L 27 13 100 100 10 Calibration 
2 L 28 14 100 100 100 Calibration 
2 L 29 15 12.5 12.5 12.5 Calibration 
2000 L 30 
01 
25 50 25 Scale up 
2000 L 31 25 50 25 Scale up 







MATLAB scripts (Ben_Yahia_et_al_segmented_regression.m and seg_reg.m) 
 
The two MATLAB scripts appended allow the segmented regression as used in the 
publication. 
It runs on Matlab Release 2013a (The Mathworks, Natick, MA, USA) and higher 
versions and requires the Statistical Toolbox supplied by The Mathworks. 
 
Ben_Yahia_et_al_segmented_regression.m 
%Script of segmented regression: 
%this script generates simulated data of seven metabolites production 
rates as a function of one growth rate variable: 
%three metabolites with 2 breakpoints, 
%two metabolites with 1 breakpoint, one metabolite with no breakpoint 
and 
%a last one completely random 
%The simulated data is stored in an xls file which shows the typical 
%structure of data used by the computations performed here. This xls 
file 
%can be used as a template for your data (in that case clear the first 
cell of the script then run the script) 
%The script loads data from the xls file then computes breakpoints and 
%segmented regression models using the subroutine seg_reg 
%Results are then displayed 
%% Simulate data and write it into an xls file 
Metab={'Abc','Def','Ghi','Klm','Nop','Qrs','Tuv'};%variable names 






%Data with two breakpoints Dataset(:,1:3) 
bp1=[-0.28 -0.25 -0.22]; 
bp2=[0.6 0.63 0.66]; 
slopes=[-5 1 5;-5 -1 5;5 -5 5]; 






bounds=[repmat(range_data(1),3,1) bp1' bp2' repmat(range_data(2),3,1)]; 
slopes_temp=[slopes(:,1) diff(slopes,[],2)]; 
for i=1:length(bp1), 
    for bo=1:3, 
        index=gr>=bounds(i,bo); 
        Dataset(index,i)=Dataset(index,i)+(gr(index)-
bounds(i,bo))*slopes_temp(i,bo); 




%Data with one breakpoint Dataset(:,4:5) 
bp1=[0.6 0.63]; 




bounds=[repmat(range_data(1),2,1) bp1' repmat(range_data(2),2,1)]; 
slopes_temp=[slopes(:,1) diff(slopes,[],2)]; 
for i=(1:length(bp1)), 
    for bo=1:2, 
        index=gr>=bounds(i,bo); 
        Dataset(index,i+3)=Dataset(index,i+3)+(gr(index)-
bounds(i,bo))*slopes_temp(i,bo); 
    end; 
end; 
  





%Random data is Dataset(:,7) 
  
%write to excel table (you can fill this table with your own data with 










%% Load data 
clear 
[Dataset,Metab]=xlsread('DATASIM_SEG.xls'); 




    Metab_mini{i}=Metab{i}(1:3);%shorter variable names 
end; 
n=length(gr);%size of data 
  
%% Computations of segmented regression 
  
seg=seg_reg(Dataset,gr); 
%seg is a structure of size nvar which contains all information about 
%segmented regression 
  
%% Display data and best model found for each metabolite 
figure('position',[240          49        1000         500]); 
for i=1:nvar, 
    subplot(2,ceil(nvar/2),i); 
    hold on 
     
    plot(gr,Dataset(:,i),'.','color',[0 0 1]);%scattergram data 
      
    %plot best model 
    grsort=sort(gr);%trick: sort data and connect points with lines to 
show segemnted regression, easier than plotting three lines 
    %identify which was the best model, choose a color for each type of 
model found 
    if seg(i).model_choice==2,%2BP is the best model 
        %build regression matrix 
        mat_reg=[ones(n,1) grsort 
double(grsort>=seg(i).values_2bp(1)).*(grsort-seg(i).values_2bp(1)) 
double(grsort>=seg(i).values_2bp(2)).*(grsort-seg(i).values_2bp(2))]; 
        col='r'; 
        suff=' - 2BP'; 
    elseif seg(i).model_choice==1,%1BP is the best model 
        mat_reg=[ones(n,1) grsort 
double(grsort>=seg(i).values_1bp(1)).*(grsort-seg(i).values_1bp(1))]; 
        col='g'; 
        suff=' - 1BP'; 




         mat_reg=[ones(n,1) grsort]; 
        col='c'; 
        suff=' - LIN'; 
    else%no model is good enough (Fisher test) 
        col='k'; 
        suff=' - NO'; 
    end; 
    %Is the segmented regression model found a good one ? Condition 
R2>0.5, 
    %indicated by a "*" in the title 
    if seg(i).r2>0.5&~isnan(seg(i).model_choice), 
        good_model='*'; 
    else 
        good_model=''; 
    end; 
    %if there was a regression model, show the lines 
    if ~isnan(seg(i).model_choice), 
        ypred=mat_reg*seg(i).beta; 
        plot(grsort,ypred,col,'linewidth',2); 
    end; 
    title([Metab_mini{i} suff good_model],'color',col); 
     
    if i==1, 
        ylabel('Production Rate'); 
        xlabel('Growth Rate'); 
    end; 
    grid on 
end; 
  
%% set of BP found by best 2BP segmented regression 
%(even if that was not the final selected model) 
disp('BP values for the best 2BP segmented regression model'); 
for i=1:nvar, 












%computes segmented regression model up to 2 breakpoints 
% 
%INPUT: 
%     Dataset       : matrix observations * variables 
%     gr            : variable to segment (growth rate in the paper) 
% 
%OUTPUT: 
%     seg is a structure with the followig fields: 
%     fstat_lin     : fisher stats for the linear model 
%     values_2bp    : Breakpoints (BP) values of the 2 BP model 
%     fstat_2bp     : fisher stats for the 2 BP model 
%     values_1bp    : BP value of the 1 BP model 
%     fstat_1bp     : fisher stats for the 1 BP model 
%     fish2_1       : fisher stat value for the 2 BP vs 1 BP model 
%     pvfish2_1     : fisher stat pvalue for the 2 BP vs 1 BP model 
%     fish1_0       : fisher stat value for the 1 BP vs 0 BP model 
%     pvfish1_0     : fisher stat pvalue for the 1 BP vs 0 BP model 
%     model_choice  : number of BP in the best model 
%     beta          : coefficient values in the best model 
%     slopes        : slope values in the best model 
%     r2            : r2 of the best model 
%     ssr           : Residual Sum of Square of the best model 
%     n             : number of observations in the data 
%     statsreglin   : stats for the linear model (no BP) 
%     statsregseg   : stats for all tested segmented models 
  
%maximum number of breakpoints = 2 (Based on previous data analysis) 
nvar=size(Dataset,2); 
  
%create a set of possible breakpoints 
rangebp=prctile(gr,[5 95]);%growth rate range 
number_steps=50;%number of possible values for breakpoints 
grsteps=linspace(rangebp(1),rangebp(2),number_steps);%sample 50 
breakpoints over the range of growth rate 
pt_middle=median(gr); 
  
%loop on all available variables 
for i=1:nvar, 
     
    idx=~isnan(Dataset(:,i));%select non-missing data 
    n=sum(idx); 
     




    statsreglin(i) = 
regstats(Dataset(idx,i),gr(idx),'linear',{'beta','covb','tstat','rsqua
re','r','fstat'}); 
    SSR_ref(i)=sum(statsreglin(i).r.^2);%reference sum of square 
    R2_ref(i)=statsreglin(i).rsquare;%reference R^2 statistics 
    seg(i).fstat_lin=statsreglin(i).fstat; 
     
    %we now compute the regression model for each pair of possible 
breakpoints 
    c1=0; 
    for bp1=grsteps, 
        c1=c1+1; 
        c2=0; 
        for bp2=grsteps, 
            c2=c2+1; 
            ok=0; 
            if (bp1<pt_middle&&bp2>pt_middle&&bp2-bp1>0.2),% We put 
each breakpoint on each side of growth rate mediane. Morever, the minimum 
distance between two breakpoints has been set to 0.2 day^-1 except if 
breakpoints are the same (case of one breakpoint) 
                mat_reg=[gr double(gr>=bp1).*(gr-bp1) 
double(gr>=bp2).*(gr-bp2)];%regression matrix  
                ok=1; 
            elseif (bp1==bp2) 
                 mat_reg=[gr double(gr>=bp1).*(gr-bp1)];%regression 
matrix  
                 ok=1; 
            end; 
            if ok, 
                statsregseg(i,c1,c2) = 
regstats(Dataset(idx,i),mat_reg(idx,:),'linear',{'beta','rsquare','r',
'fstat'}); 
                ssrbp{i}(c1,c2)=sum(statsregseg(i,c1,c2).r.^2);%sum of 
residual square 
            end; 
        end; 
    end; 
     
    %which bp are the best ? (case of two breakpoints) 
    ssrbp{i}(ssrbp{i}==0)=NaN; 
    [mintemp,c1min]=nanmin(ssrbp{i}); 
    [~,c2min]=nanmin(mintemp); 
    c1min=c1min(c2min(1)); 





    seg(i).fstat_2bp=statsregseg(i,c1min,c2min).fstat;%store fisher 
stats for the whole model 
     
    %case with only one BP 
    [~,c1min1bp]=nanmin(diag(ssrbp{i})); 
    seg(i).values_1bp=grsteps(c1min1bp); 
    seg(i).fstat_1bp=statsregseg(i,c1min1bp,c1min1bp).fstat; 
     
    %comparison two BP vs one BP: Fisher statistics and pvalue 
    seg(i).fish2_1=(ssrbp{i}(c1min,c2min)-
ssrbp{i}(c1min1bp,c1min1bp))/(n-3-1-(n-2-
1))/ssrbp{i}(c1min1bp,c1min1bp)*(n-2-1);%same bp so it is two segments 
instead of three 
    seg(i).pvfish2_1=1-fcdf(seg(i).fish2_1,abs(n-3-1-(n-2-1)),n-2-1); 
     
    %comparison of one BP with simple linear regression 
    seg(i).fish1_0=(ssrbp{i}(c1min1bp,c1min1bp)-SSR_ref(i))/(n-2-1-(n-
2))/SSR_ref(i)*(n-2); 
    seg(i).pvfish1_0=1-fcdf(seg(i).fish1_0,abs((n-2-1-(n-2))),(n-2)); 
     
    %final segmented model - store results 
    if 
seg(i).pvfish2_1<0.05/nvar&&seg(i).fstat_2bp.pval<0.05/nvar,%best model 
is 2BP. threshold is "bonferronized" 
        seg(i).model_choice=2;%number of breakpoints 
        seg(i).beta=statsregseg(i,c1min,c2min).beta; 
        
seg(i).slopes=[cumsum(statsregseg(i,c1min,c2min).beta(2:end))'];%slope
s in a segemented regression 
        seg(i).r2=statsregseg(i,c1min,c2min).rsquare; 
        seg(i).ssr=ssrbp{i}(c1min,c2min);%residuals sum of square 
    elseif 
seg(i).pvfish1_0<0.05/nvar&&seg(i).fstat_1bp.pval<0.05/nvar,%best model 
is 1BP 
        seg(i).model_choice=1; 
        seg(i).beta=statsregseg(i,c1min1bp,c1min1bp).beta; 
        
seg(i).slopes=[cumsum(statsregseg(i,c1min1bp,c1min1bp).beta(2:end))'];
%slopes in a segemented regression 
        seg(i).r2=statsregseg(i,c1min1bp,c1min1bp).rsquare; 
        seg(i).ssr=ssrbp{i}(c1min1bp,c1min1bp);%residuals sum of square 
    elseif seg(i).fstat_lin.pval<0.05/nvar,%best model is Linear (0BP) 
        seg(i).model_choice=0; 




        seg(i).slopes=seg(i).beta(end);%slopes in a segemented 
regression 
        seg(i).r2=R2_ref(i); 
        seg(i).ssr=SSR_ref(i);%residuals sum of square 
    else 
        seg(i).model_choice=NaN; 
        seg(i).beta=NaN; 
        seg(i).slopes=NaN;%slopes in a segemented regression 
        seg(i).r2=NaN; 
        seg(i).ssr=NaN;%residuals sum of square 
    end; 
    seg(i).n=n; 
    seg(i).statsreglin=statsreglin(i); 


















R scripts  
 
The R scripts appended allow the segmented regression in R with Shiny, an open 
source R package that provides a web application. 
It runs on R 3.2.2 (Copyright (c) 2015 The R Foundation for Statistical Computing) 
or RStudio v1.0 (Copyright (c) 2015 The R Foundation for Statistical Computing) and 
higher versions. The data should be structured like for the MATLAB script but the 






#script to perform a segmented linear regression with Shiny(R) 
ui <- fluidPage( 
  titlePanel("Segmented linear regression"), 
  sidebarLayout( 
    #define the inputs and the outputs 
    sidebarPanel( 
      fileInput('file1', 'Choose CSV 
File',accept=c('text/csv','text/semicolon-separated-
values,text/plain','.csv')), 
      hr(), 
      uiOutput("varselect"), 
      uiOutput("varselect2"), 
      uiOutput("breakpoint"), 
      fluidRow( 
        textOutput("txt"), 
        textOutput("text"), 
        tableOutput("tabest"), 
        h3(textOutput("Information")), 
        tableOutput("Breakpoint")        
      )), 
    mainPanel( 
      fluidRow( 
        p(strong("(2016)"), ("Methodologie developped by"),em(" Bassem Ben 
Yahia et al."),("bassem.benyahia@ucb.com")),     
        titlePanel("Plots"), 
        column(6,plotOutput("hist")), 
        column(6,h5(plotOutput("res"))) 
      ), 
      fluidRow( 
        column(6,tableOutput("tabrquared")), 
        column(6,tableOutput("tab"))     
      )))) 
 
server <- function(input, output) { 




    infile<-input$file1 
    #if no dataset loaded, return NULL 
    if (is.null(infile)){ 
      return(NULL) 
    } 
    #if datased available, read it and save it in Dataset 
    read.csv(infile$datapath,";",h=T) 
  })   
  #Give a value to all output (if Dataset available) 
  output$varselect<-renderUI({ 
    infile<-input$file1 
    if (is.null(infile)){ 
      #No dataset available 
      h4("No variable: please choose a CSV file",style="color:red") 
    }else{ 
      #Dataset available: define the variables presents (variable2 and 
variable) 
      #then define the new input (selectinput and breakpoints selection) 
      cols<-names(Dataset()) 
      output$varselect2<-renderUI({selectInput("variable2", "X 
variable:",choices=cols)}) 
      output$breakpoint<-
renderUI({numericInput("bp","Breakpoints",0,min=0,max=3,step=1)}) 
      selectInput("variable", "Y variable:",choices=cols)      
    } 
  }) 
  #Plot and perform the statistical analysis 
  output$hist<-renderPlot({ 
    infile<-input$file1 
    if (is.null(infile)){ 
      points(NULL)                  
    }else{           
      Dati<-Dataset()  
      x<-as.numeric(unlist(Dati[input$variable2])) 
      y<-as.numeric(unlist(Dati[input$variable])) 
      variable<-input$variable 
      variable2<-input$variable2 
      if(input$bp==0){ 
        
plot(x,y,xlab=variable2,ylab=variable,pch=17,col="black");abline(lm(y~x),lwd=
5) 
        output$tab<-renderTable({anova(lm(y~x))}) 
        output$res<-
renderPlot({plot(x,residuals(lm(y~x)),xlab=input$variable2,ylab="redisuals",p
ch=18);abline(0,0,lwd=5,lty=3,col="blue")}) 
        h3(output$Information<-renderText({"Summary"})) 
        r.table<-
data.frame(data.frame(summary(lm(y~x))$adj.r.squared),data.frame(summary(lm(y
~x))$r.squared)) 
        colnames(r.table)<-c("R.squared","Adj.R.squared") 
        output$tabrquared<-renderTable({r.table}) 
        emptytab<-data.frame("") 
        colnames(emptytab)<-"" 
        rownames(emptytab)<-"" 
        output$tabest<-renderTable({emptytab}) 




        if (input$bp==1){ 
          o.seg<-
segmented(lm(y~x),seg.Z=~x,control=seg.control(display=FALSE,it.max = 60)) 
          
plot(o.seg,conf.level=0.95,shade=TRUE,xlab=variable2,ylab=variable,col="green
",lwd=5);points(x,y,pch=17) 
          output$tab<-renderTable({anova(o.seg,lm(y~x))}) 
          output$res<-
renderPlot({plot(x,residuals(o.seg),xlab=input$variable2,ylab="redisuals",pch
=18);abline(0,0,lwd=5,lty=3,col="blue")}) 
          output$Information<-renderText({"Breakpoint"}) 
          breakpointtable<-data.frame(summary(o.seg)$psi) 
          rownames(breakpointtable)<-"Breakpoint"  
          output$Breakpoint<-renderTable({breakpointtable}) 
          t.slope<-data.frame(slope(o.seg)) 
          interc<-data.frame(intercept(o.seg)) 
          t.slope<-t.slope[1] 
          colnames(t.slope)<-"Est." 
          n.table<-rbind(t.slope,interc) 
          row.names(n.table)<-c("b2","b1","a2","a1") 
          output$tabest<-renderTable({n.table},rownames=TRUE) 
          r.table<-
data.frame(data.frame(summary(o.seg)$adj.r.squared),data.frame(summary(o.seg)
$r.squared)) 
          colnames(r.table)<-c("R.squared","Adj.R.squared") 
          output$tabrquared<-renderTable({r.table}) 
           
        }else{ 
          if (input$bp==2){ 
            o.seg<-
segmented(lm(y~x),seg.Z=~x,psi=c(qnorm(0.5,mean(x),sd(x)),qnorm(0.85,mean(x),
sd(x))),control=seg.control(display=FALSE,it.max = 60)) 
            
plot(o.seg,conf.level=0.95,shade=TRUE,xlab=variable2,ylab=variable,col="red",
lwd=5);points(x,y,pch=17) 
            output$tab<-
renderTable({anova(o.seg,segmented((lm(y~x)),seg.Z=~x))}) 
            output$res<-
renderPlot({plot(x,residuals(o.seg),xlab=input$variable2,ylab="redisuals",pch
=18);abline(0,0,lwd=5,lty=3,col="blue")}) 
            output$Information<-renderText({"Breakpoints"}) 
            breakpointtable<-data.frame(summary(o.seg)$psi) 
            rownames(breakpointtable)<-c("Breakpoint 1","Breakpoint 2")  
            output$Breakpoint<-renderTable({breakpointtable}) 
            t.slope<-data.frame(slope(o.seg)) 
            interc<-data.frame(intercept(o.seg)) 
            t.slope<-t.slope[1] 
            colnames(t.slope)<-"Est." 
            n.table<-rbind(t.slope,interc) 
            row.names(n.table)<-c("b3","b2","b1","a3","a2","a1") 
            output$tabest<-renderTable({n.table},rownames = TRUE) 
            r.table<-
data.frame(data.frame(summary(o.seg)$adj.r.squared),data.frame(summary(o.seg)
$r.squared)) 
            colnames(r.table)<-c("R.squared","Adj.R.squared") 




          }else{ 




            
plot(o.seg,conf.level=0.95,shade=TRUE,xlab=variable2,ylab=variable,col="viole
t",lwd=5);points(x,y,pch=17) 
            output$tab<-
renderTable({anova(o.seg,segmented(lm(y~x),seg.Z=~x,psi=c(qnorm(0.5,mean(x),s
d(x)),qnorm(0.85,mean(x),sd(x)))))}) 
            output$res<-
renderPlot({plot(x,residuals(o.seg),xlab=input$variable2,ylab="redisuals",pch
=18);abline(0,0,lwd=5,lty=3,col="blue")}) 
            output$Information<-renderText({"Breakpoints"}) 
            breakpointtable<-data.frame(summary(o.seg)$psi) 
            rownames(breakpointtable)<-c("Breakpoint 1","Breakpoint 2"," 
Breakpoint 3")  
            output$Breakpoint<-renderTable({breakpointtable}) 
            t.slope<-data.frame(slope(o.seg)) 
            interc<-data.frame(intercept(o.seg)) 
            t.slope<-t.slope[1] 
            colnames(t.slope)<-"Est." 
            n.table<-rbind(t.slope,interc) 
            row.names(n.table)<-c("b4","b3","b2","b1","a4","a3","a2","a1") 
            output$tabest<-renderTable({n.table},rownames=TRUE) 
            r.table<-
data.frame(data.frame(summary(o.seg)$adj.r.squared),data.frame(summary(o.seg)
$r.squared)) 
            colnames(r.table)<-c("R.squared","Adj.R.squared") 
            output$tabrquared<-renderTable({r.table}) 
          } 
        }}} 
  })                   
} 





Figure S4 Screenshot of an example of application of the R script 
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